Health-Tech Company Alcidion to List on ASX in Reverse Takeover

18th August 2015, BRW by Paul Smith

Australian healthcare informatics provider Alcidion will list on the Australian Securities Exchange later this year after agreeing to be taken over by mining shell company Naracoota Resources, in a $12 million deal to kickstart its ambitious US expansion plans.

The company, which was founded by the former chairman and CEO of the South Australian Health Commission Ray Blight and Professor Malcolm Pradhan, has just completed a $2 million capital raise, and is looking to rapidly scale up its US presence to take advantage of looming opportunities for health tech companies as a result of the ObamaCare Affordable Care Act.

The transaction is being backed by Allure Capital, the private investment vehicle of technology entrepreneur Nathan Buzza, who is also now Alcidion’s executive director, as well as BlueSky Private Equity and Patersons Securities. Mr Buzza was previously the second-largest shareholder of listed clinical tech provider Azure Healthcare, which boomed from 3.3¢ to 34¢ during his 2½-year tenure.

To read the full story, please click here.


Alcidion Wins a 2015 Impact Award

November 11th 2015

Alcidion Corporation, a leading health informatics company based in Adelaide has won an award at the 2015 Impact Awards.

Celebrated at the Adelaide Convention Centre with 350 guests on Tuesday November 10, Alcidion was one of three winners of the 2015 awards.

The Impact Awards recognise South Australian companies who are true ‘gazelles’ of the economy, with a business, model, management and solution which are world class. The event is organised by a committee and support staff who work with local business leaders and ambassadors. It is a joint and coordinated effort by the local business community to generate home grown solutions to improve commercial and research outcomes in the state.

Crowd Mobile’s New App Connecting Users with TV Stars

1st December 2015, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) is pleased to announce that it has entered into a partnership with IMA Consultancy in the UK to develop an App that allows users to connect with TV stars.

The new App will be initially hosted by two of the most influential TV stars in the UK – Gary Beadle from MTV’s number 1 show Geordie Shore, and high profile UK comedian Dapper Laughs, who collectively have over 7 million fans across social media.

The agreement with IMA, who represent Gary Beadle & Dapper Laughs, will see Crowd Mobile designing, developing, and maintaining the App, while IMA will be responsible for promoting the App to the relevant target market. Ownership of the App will remain with Crowd Mobile, with revenues generated to be shared between both companies.

To read the full announcement, please click here

TFS Unaudited Financial Report Ending 30 Sept 15

30th November 2015, ASX Announcement

TFS Corporation Limited (“TFS”, ASX: TFC), the world’s largest owner and manager of commercial Indian sandalwood plantations, today reported a net profit after tax of $40.5 million for the three months ended 30 September 2015, compared to $18.6 million in the previous corresponding period (“pcp” , being the three months to 30 September 2014).

Cash EBITDA, which removes the impact of non-cash revenues and unrealised foreign exchange movements, was $6.4 million (pcp: loss of $$6.2 million).

The strong improvement in earnings reflected significant growth in both cash and non-cash revenues, with total revenue for the quarter up 62% to $109 million (pcpL $67.7 million). The growth in cash revenue was driven by an increase in establishment fees and land sales to $23.9 million (pcp: $2.8 million), principally from the sale of 214ha of new Indian sandalwood plantations to the Church Commissioners for England in September 2015.

To read the full announcement, please click here

To read the Un-audited Financial Report, please click here

Martin Jetpack Company Shareholder Newsletter November 2015

30th November 2015, ASX Announcement

This newsletter covers a number of topics including an Investor Relations Update and an overview of the Dubai & Munich air shows. It also includes information on the release of a new video of P12.3 test flights, details on our new Aircraft Maintenance Software (AMS), an update on staffing, notification of our participation at Intersec 2016 in Dubai, and a public manned display in China in December.

Over the period 8-12 November 2015, Martin Aircraft Company exhibited at the Dubai Air Show (DAS2015). For the Martin Aircraft Company, the air show has been an overwhelming success both in terms of the business and the opportunity to introduce to the regional community of the latest model of the Martin Jetpack, the world’s first practical personal jetpack, with potential usage spaning search and rescue, recreational and commercial applications, both manned and unmanned.

To read the full announcement, please click here

Medication Adherence Platform, MedAdvisor, Lists on the ASX

1st December 2015, ASX Announcement

  • MedAdvisor raises $5m in oversubscribed public offer
  • MedAdvisor commences trading under ticker code MDR
  • MedAdvisor announces new medication training relationship with Amgen

MedAdvisor Limited (MedAdvisor or Company) an Australian software developer focused on improving health outcomes by placing patients at the centre of connected health platforms, has been re-admitted to the Australian Securities Exchange. MedAdvisor, trading under the ticker code MDR, commences trading today following a reverse takeover of Exalt Resources Limited (ASX: ERD) by MedAdvisor International Pty Ltd.

The company also announces it has entered a new medication training relationship with Amgen, the world’s largest independent biotechnology company, which currently markets eight products in Australia for the treatment of cancer, kidney disease, bone disease and other serious illnesses.

To read the full announcement, please click here

DomaCom Ltd Update: $5.5m Raised in the Last 4 Weeks! Pre-IPO Round Closing Soon

Just to update you on DomaCom; in the last 4 weeks, Axstra Capital has raised $5.5m into their current pre-IPO round. ASX listed asset manager Contango Group has also invested $2m into this round ( Contango is an ASX listed fund manager, so to receive their commitment at the pre-IPO level is a major funding milestone for DomaCom.

As of today there is $1.5m remaining of the current $10m pre-IPO round and we anticipate to close this by mid-December.

As a result of all this pre-IPO activity, CEO Arthur Naoumidis announced at the company’s AGM (held last week), that DomaCom will immediately commence the IPO process, with a target listing date of April/May 2016. A special resolution to change the company’s constitution to an ASX compliant version was put to shareholders at the AGM and it was unanimously supported.

The IPO is expected to bring in a further $10m, thus providing DomaCom with circa $20m to accelerate its expansion program. Once DomaCom is listed, Arthur believes that many more Financial Planning groups will sign up and use DomaCom as they will no longer be perceived as a “start-up”.

If you are contemplating becoming a shareholder prior to the IPO, the opportunity is still available. Shares are $0.50 each (min investment $50,000/100,000 shares).

Alternatively you can wait till 2016 and invest into the IPO. The only potential downside is that if either one of 2 significant milestones is met before the IPO, the share price is likely to be significantly higher than the $0.50 pre-IPO price. Arthur is confident of achieving at least one of these milestones prior to then, so we do expect that the IPO price will be at a premium to the pre-IPO price. No guarantees of course!

DomaCom is shaping up nicely and we are really excited about the next 12 mths, now that the funding is in place for them to significantly accelerate their growth.


H. Lee Moffitt Cancer Center Leukaemia Oncologist Joins SAB

30th November 2015, ASX Announcement

Clinical stage oncology company Prescient Therapeutics Ltd (PTX) is delighted to announce the appointment of the H. Lee Moffitt Cancer Center’s Professor Jeffrey Lancet MD to PTX’s Scientific Advisory Board (SAB).

Professor Lancet is a medical oncologist whose work involves the development and implementation of clinical trials using small molecule inhibitors in acute leukemias.

This is of particular interest to PTX ahead of an upcoming clinical trial in Acute Myeloid Leukemia (AML) in early 2016.

Professor Lancet was an investigator on PTX’s earlier Phase 1  AML clinical trial conducted at MD Anderson and Moffitt Cancer Center in 32 patients with advanced haematologic malignancies.

To read the full announcement, please click here

More World-Wide Sales Traction for Kube Systems in UK

Kube Systems has gained more world-wide sales traction for its portable charging solutions with the announcement of a new distributor in the United Kingdom – and sales-boosting first order.

Kube’s new distributor, Airwave Europe, is one of the UK’s leading suppliers, installers and integrators of digital television and audio visual equipment.  It specialises in distribution to hotels.  The signing of the agreement was backed up with an initial order of $100,000 worth of product.

The new agreement comes hot on the heels of the news that Marriott International will buy Starwood Hotels and Resorts for US$12 billion, making it the biggest hotel operator in the world. Marriott was the first hotel group to approach the Kube founder for a solution to customer smartphone charging problems – and it has been a consistent buyer of the products ever since.

Atomo Diagnostics Wins State Funding to Make HIV Self Test

November 28, 2015,

Atomo Diagnostics is delighted to announce that the company has been awarded a grant of A$1.8 million (US$1.3M) from the New South Wales Medical Device Fund 2015-2016 for the development of a self-test for rapid detection of HIV. The Atomo HIV Self Test will be easier to use than any HIV self-test available globally, and will provide users with clear and accurate test results within minutes.

Atomo Diagnostics is a Sydney-headquartered healthcare company that designs, develops and commercialises rapid diagnostic tests that offer best-in-class safety and ease-of-use. Atomo is Australia’s only manufacturer of rapid diagnostic tests for detection of HIV, and currently sells most of its tests to professional users in Africa.

The NSW Medical Device Fund is an annual merit-based commercialisation programme run by the NSW Government Department of Health. The Fund helps to promote and support the development of new and innovative medical devices in NSW, with particular focus on technologies that have the potential to provide significant global health benefits.

To read the full story, please click here

Big Un Limited AGM Presentation

27th November, ASX Announcement

Highlights FY15:

  • Successful ASX listing. Strong demand from investors
  • Member based increased by 550% since January 2015 to over 13,000 today
  • Solid financial performance
    - FY2015 revenues of $0.9 million
    - Quarterly revenue growth of 50% for the past two quarters with ~$600,000 forecasted for December quarter, making the H1 2016 total already above FY2015
  • Established a well credentialed and experienced advisory board, including leading Google executives
  • Expanded sale and distribution capabilities through partnerships
  • International Footprint established in Australia New Zealand, UK, US, Hong Kong and Singapore
  • Over 10,000 videos produced to date
  • BRTV mobile application launched

To read the full announcement, please click here

BioDiem 2015 Entitlement offer Prospectus

2015 BioDiem Prospectus

Our BioDiem Offer closes 14th December

  • to raise $448,000 at $0.08 per share
  • placement of $298,000 completed

Funds will be used to support our commercial flu vaccine program and OpalBiosciences’ antimicrobial development.

The Offer documentation will be posted to shareholders today to the addresses held by the share registry, Computershare.

For any other enquiries, please contact

Further Details

BioDiem Melbourne Showcase & Invite: Sydney Presentation

BioDiem Showcase

BioDiem’s CEO, Julie Phillips presented at the Wholesale Investor Melbourne Showcase, held at Rydges Hotel in Melbourne on 25th November 2015. The event was designed to showcase innovative Australasian companies for an audience of investors. The BioDiem presentation focused on BioDiem’s revenue-generating LAIV Vaccine program, and its antimicrobial BDM-I, which is being commercialised through BioDiem’s subsidiary, Opal Biosciences.

To see the full presentation, please click here. If you would like to attend the presentation in Sydney, the event details and RSVP link are within this email.


Invite: Sydney Presentation 

Wholesale Investor – Sydney Capital Expo and Small Cap Showcase December 2015.

Date: Friday, 04 December 2015
Time: 10.00am – 3.00pm
Venue: Menzies Hotel, 14 Carrington Street, Sydney NSW 2000
Catering: Lunch will be supplied throughout the event

Register here

APN Review November 2015: Thinking outside the (residential) box, Singapore REITs reporting season insights and more…

Residential property dominates the news and is a favourite topic of choice for Australians. Skyrocketing prices, social concerns regarding affordability, speculation of a looming bust and the eleventh series of “The Block”, you would be forgiven for thinking that the only type of property is ‘residential’.

Commercial property in Australia is worth a staggering $0.70 trillion (CoreLogic RP Data, October 2015). There are compelling reasons for investors to look beyond the residential home and broaden their investment portfolio to include commercial property.

In this month’s Hot Topic , we explore the differences between residential and commercial property and outline the benefits of including commercial property at a portfolio level.

Singapore REITs APN’s top three reporting season insights

Singapore listed REITs recently completed announcing their quarterly earnings results.

Click here to take a look at our top three insights.

Interview with APN Executive Director Tim Slattery on the Finance News Network

Tim Slattery talks to Carolyn Herbert, Finance News Network about FY15 results and plans for future growth.

Click here to watch the interview or access the transcript.

APN Convenience Retail Property Fund launch 7.20%pa+¹ initial forecast distribution yield paid monthly

APN announced the launch of the APN Convenience Retail Property Fund, the Group’s latest unlisted direct property fund.

Click here to find out more about the Fund.

Investment opportunities – register your interest

APN is currently working towards launching a number of new investment opportunities.

To register your interest in these and other opportunities, please click here.

MD Anderson Leukaemia Expert Joins Prescient Therapeutics SAB

26th November 2015, ASX Announcement

Cancer drug development company Prescient Therapeutics Ltd (ASX: PTX) is delighted to announce the appointment of an internationally regarded leukemia authority to its Scientific Advisory Board.

Professor Farhad Ravandi MD is based at the MD Anderson and Moffitt Cancer Center, which is one of the world’s most prestigious cancer institutions.

He currently holds position as Professor and Chief, Section of Developmental Therapeutics within the Department of Leukemia (AML) in early 2016.

Professor Ravandi is actively involved in clinical and translational research for the treatment of patients with various hematological malignancies, with a particular focus on leukemias.

To read the full announcement, please click here

Booodl: Launch day + Have you used Apple’s 3D touch yet?

You may have received our email that went out to all users today announcing our nationwide launch. More on that in a bit!

I wanted to reach out and share my latest video on Apple’s 3D touch functionality. In short, I’m blown away. We’re doing some very cool things with it in the Booodl iOS app to help save time and navigate with ease and efficiency. Take a look:

For those of you that missed the announcement this morning, here’s the crux of it:

  • New look: we’ve revamped our look and feel to be more fun and more reflective of who we are as a company (the new colours in this email are your first peak!).
  • New website: now when you visit the Booodl homepage you can enter something you want, the location where you’d like to get it, and see all the stores that sell it. Give it a go and let us know what you think!
  • New & Impoved App: you can store your favourite brands and categories in Booodl, we’ve simplified the way you search and add products, and iOS users can make the most of 3D touch!
  • New stores: We’re expanding our retail network daily, but at launch over 15,000 stores can be found in Aus and more than one million products are listed.

You can read about the update in full here.

TFS Issues US$25m of Additional Notes to US Debt Market

26th November 2015, ASX Announcement


  • Issuance of additional US$25 million under the provisions of exiting Senior Secured Notes
  • Effective yield to maturity of 8.50% – significantly below the cost of TFS’s existing debt
  • Provides the funding for the recently announced programme to acquire trees from MIS growers

TFS Corporation Limited (“TFS”, ASX: TFC), the world’s largest owner and manager of commercial Indian sandalwood plantations, today announced the issuance of US$25 million of Additional Notes under the provisions of its existing Senior Secured Notes. The Additional Notes will be issued at a premium to par to 5.75% and have the same terms and conditions as the existing Notes.

Mr Frank Wilson, Managing Director of TFS, said: “The issuance provides TFS with additional capital on flexible terms at an attractive rate. The proceeds from the issuance provide TFS with further balance sheet strength to support our growth, including the funding of the acquisition of Indian sandalwood interests owned by MIS growers.

To read the full announcement, please click here

YuuZoo’s Q3/2015 Revenues Grew 93% to S$ 42.6 Million

12th November 2015, YuuZoo

Singapore-listed YuuZoo Corporation Limited (“YuuZoo”) (SGX: AFC) is pleased to report a 93% growth in revenue for the nine months ended 31 September 2015, to S$ 42.6 million (US$ 30.0 million) and an EBITDA of S$ 22.0 million (US$14.2 million), up 692% over the same period last year.

With growth in all key areas, key contributors to the Q3 numbers were e-commerce, e-sports activities in China and the launch of a new sport franchise operation in the UK.

Q3/2015 Operational Highlights

  • In June, YuuZoo announced the formation of YuuGames—a joint venture with XG AMA, a leading organizer of e-sport events in China.  Under the joint venture (JV) agreement, XG AMA is committed to deliver a minimum of 5 million active paying users and a minimum profit of 1.5 million RMB during the first 12 months of operations.
  • YuuGames has in Q3/15 signed several major deals. The Company has secured the co-hosting and naming rights for Electronic Sports China Cup (ESCC), China’s major e-sport event run in conjunction with China’s Ministry of Culture. YuuGames also gained co-hosting rights for China Internet Gaming (CIG), another major competition in conjunction with the Ministry of Industry and Internet Technology. Having secured two of China’s largest e-sports events, YuuGames now is amongst the leading players in China in this fast growing and highly lucrative space. China is estimated to have more than 445 million gamers. In addition to the direct revenues from YuuGames, the competitions drive users to YuuZoo’s virtual shopping mall, raises YuuZoo’s profile and contributes to revenues and profits.
  • In Q3, YuuZoo acquired the user data of more than 26 million mobile game downloads and 11 leading mobile games from leading Chinese game developer Camigo Media. The acquired user base significantly increases YuuZoo’s reach in China, establishes the Company in China’s US$ 30 billion mobile games market, and like the e-sport events drives new users to YuuZoo’s virtual shopping mall.

To read the full announcement, please click here

TEHO Enters Agreement with Teco Electric & Machinery


The Board of Directors (the “Board”) of TEHO International Inc Ltd. (the “Company” and together with its subsidiaries, the “Group”) wishes to announce that TEHO Ropes & Supplies Pte. Ltd. (“TRSPL”), a wholly-owned subsidiary of the Company, had, on 20 November 2015, entered into an option agreement (the “Option Agreement”) to grant an option (the “Option”) to Teco Electric & Machinery (Pte.) Ltd (the “Purchaser”) to purchase from TRSPL the property located at 47 Tuas Avenue 9, Singapore 639190 (the “Property”) at a purchase consideration of S$14,380,000 (the “Consideration”) and on the terms and subject to the conditions of the Option Agreement (the “Proposed Disposal”).


Teco Electric & Machinery (Pte.) Ltd is a company incorporated in Singapore with its registered office located at 18 Chin Bee Drive, Singapore 619865, and is principally involved in the business of manufacturing and repairing of electric motors, refrigerating, air-conditioning and ventilating machinery and equipment except household refrigerators.

The Purchaser is an unrelated third party. The Company, its Directors and controlling shareholders are not related to the Purchaser.


The Property is a single-storey warehouse and has a land area of 6,931.8 square metres. It is a leasehold property with a 30-year lease commencing 1 May 1991 with an option to renew for another 30 years granted by Jurong Town Corporation. At present, the Property is used as a
warehouse primarily for the storage of TRSPL’s fibre ropes.

Based on the independent valuation of the Property commissioned by the Group and undertaken by the independent professional valuer, CKS Property Consultants Pte Ltd, the open market value ascribed to the Property as at 30 June 2015 in its valuation report dated 30 June 2015 (“Valuation Report”) was S$13,200,000 (the “Valuation”). The valuation method adopted was market comparison method.

To read the full announcement, please click here

IEV To Tackle Corrosion Control in Vietnam

November 2015, IEV

IEV Oil & Gas Technologies, a wholly owned subsidiary of IEV Holdings Limited, in association with Oxifree, was awarded a corrosion control contract by NamConSon Pipeline which is a subsidiary of PetroVietnam Gas. IEV will carry out the corrosion prevention services for the bolts, nuts and flanges at the gas pipeline located at southern province of Ba Ria-Vung Tau, Vietnam. This is the fourth project awarded to IEV since it introduced the environmentally friendly anti-corrosion coating to the Vietnam market in 2013.

IEV is the representative for USA based- Oxifree Global LLC to market their organic thermoplastic corrosion control product to Vietnam, Malaysia and Brunei. The Oxifree TM198 is a sprayable polymeric resin coating for the protection of metallic components that meets and exceeds the expectation of corrosion prevention coatings. The cost-effective product contains active inhibitors which provide protection against many corrosive contaminants. The reusable product also complements the suite of maintenance utilized for oil and gas facilities rejuvenation.

To read the full article, please click here

AsiaPhos Continues its Growth Momentum in 3Q2015

9th November 2015, AsiaPhos

  • Gross profit margin increased to 18%, from 16% previously, on the back of a reduction in mining levy and lower production costs
  • Excluding one-off non-cash accounting expense of 2.4 million, operations continued to record higher revenues, higher profits and increased cash flows.

AsiaPhos Limited (“AsiaPhos” and together with its subsidiaries, the “Group”), a Singapore-headquartered mineral resources company focused on exploring and mining phosphate with a vertically-integrated business model, reported higher revenue, gross profit and operating cash flows for the quarter ended 30 September 2015 (“3Q2015″)

However, the bottom line was affected by the recognition of a non-recurring accounting charge of $2.4 million, which was in compliance with FRS103 Business Combinations, upon completion of the acquisition of LY Resources Pte Ltd

To read the full announcement, please click here

To view the Financial Statements, please click here

OncoSil Medical Interview on CE Mark and Growth Plans

26th November 2015, ASX Announcement

OncoSil Medical Limited (ASX:OSL) (OncoSil Medical, the Company) is pleased to provide details of an interview with Chief Executive Officer and Managing Director Daniel Kenny and Finance News Network  to discuss the Company’s CE Mark progress and growth plans.

The interview can be viewed via the OncoSil Medical company website; via this link: Media interview on CE Mark and Growth Plans 

OncoSil Medical is focused on the commercialisation of its lead product candidate, the OncoSilTM localised radiation treatment for cancer. It is concurrently seeking a Conformité Européenne (CE) Mark for OncoSilTM for pancreatic and primary liver cancer (HCC), which would facilitate commercialisation in the European Union and other major markets (including Australia, Canada and Singapore), and US approval via the US FDA.

The Company was granted a Fast Track review for its CE Mark with the European regulator in October this year and expects to receive the outcome of its CE Mark application in the near future.

To read the full announcement, please click here

Leaf Resources Chairman’s Address to Shareholders and Managing Director’s Presentation

25th November 2015, ASX Announcement

Ken Richard, our Managing Director will be giving you a Company update immediately following my address, but let me pick out some of the highlight achievements over the past year:

  • Expansion of the range of feedstocks to include popular, corn stover and palm oil waste in addition to bagasse and Eucalyptus;
  • Incorporation of a glycerol recycling step to the Glycell process which will not only save considerable input cost but which also purifys the glycerol;
  • An independent modelling study which projects a substantial operating and capital cost advantage for Glycell over the current industry practice of dilute acid pretreatment;
  • A second modelling study for production of a renewable chemical which projected an after tax IRR of 81% (US$720 million)
  • And lastly, the setting up of jointly funded developmental and commercialistion projects with four companies that span the use of the Glycell process on poplar and forestry waste, agricultural waste, Radiata pine and mushroom straw waste.

To read the full announcement, please click here

To view the Managing Director’s Presentation, please click here


Altech Optimises Kaolin Beneficiation Plant Location

26th November 2015, ASX Announcement


  • Kaolin benefication plant to be located at the Company’s HPA plant site in Johor, Malaysia
  • Lower capital and operating costs for kaolin benefication
  • Detailed design and optimisation work continues

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide an update on the detailed design work that is currently underway for its proposed high purity alumnia (HPA) project. Detailed design commenced in September 2015, following the appointment of General Manager Operations Dr Jingyuan Liu and is being undertaken with the assistance of Simulus Engineering, a Perth based multidiscipline engineering consultancy and M+W Group, the EPCM contractor for the Project.

To read the full announcement, please click here.  

Additional Placement Raises $1.0 million for Prescient Therapeutics

24th November 2015, ASX Announcement

Cancer drug development company Prescient Therapeutics Limited (ASX: PTX) (‘Prescient’, ‘PTX’ or ‘the Company’) advises that following the oversubscribed Share Purchase Plan (‘SPP’), the Company has subsequently raised approximately $1.0million. The Company is completing an additional top up placement of approximately 19.3 million fully paid ordinary shares at $0.054 (5.4 cents) per share, which is the same price as the SPP issue price. Together with the recently completed SPP, PTX has raised approximately $2.0 million, exceeding the Company’s expectations.

PTX expects these funds to provide for efforts to achieve multiple milestones across its clinical programs over the next 12 to 18 months.

To read the full announcement, please click here

Big Un Limited Q4 Revenue Guidance & Research Report

25th November 2915, ASX Announcement


Big Un Limited reports strong continued growth with revenues for the December 2015 quarter expected to reach over $600,000, a 50% increase on September 2015 quarter

Strong revenue growth also represents an average quarterly growth of 50% driven by continues expansion of the Company’s member base and ability to convert over 45% of their growing member pipeline

Wise Owl research report has been released. This report is available for download on

Member base accelerates, currently totaling 13,000 members, representing approximately 400 SMEs per week

Key drivers for FY 2061 growth include overseas sales partnerships including CDM Direct Communication Services, other marketing partnerships and initiatives and the full launch of the BRTV mobile app which opens up significant growth potential in one of the fastest growing areas of advertising (worth US$50bn in 2015)

To read the full announcement, please click here

Analytica AGM Proxy Voting Results & Presentations

24th November 2015

Analytica Ltd (ASX: ALT) advises that all resolutions, at the company Annual General Meeting held this morning in Brisbane, were passed by a show of hands.

In addition, Analytica is pleased to provide links to the following presentations shown to shareholders this morning.

Download Proxy Voting Results
Download Chairman’s Address
Download CEO Presentation

Folkestone Investor Updates November 2015

24th November 2015

Non-Residential Investment Performance – Best Year Since the GFC

Non-residential real estate has delivered an impressive 12.0% total return in the year to 30 September 2015 – its best performance since the GFC.

According to the PCA/IPD Australian Property Index, which tracks the performance of more than 1,350 non-residential assets worth more than $150 billion, non-residential real estate outperformed equities (-0.7%) and bonds (6.9%) during the past year.

To read more please click here.

Real Estate Social Infrastructure Coming of Age

Investors are increasingly turning their attention to real estate social infrastructure sectors such as childcare, seniors housing (manufactured housing, retirement villages and aged care), student accommodation, government premises (police stations, courthouses, etc), medical and health facilities as legitimate investment options.

 Much of the real estate media focus is on large office buildings, major shopping centres and infrastructure assets like toll roads and ports. Social infrastructure features solid demand drivers, the evolution of tenants from cottage industry operators and attractive investment characteristics. We expect real estate social infrastructure (both listed and unlisted) to attract more longer-term investment capital and become a viable component of many more real estate investment portfolios.

To read more please click here.

Non-Residential Quarterly Performance

A summary of the latest investment performance for non-residential property according to the Property Council/IPD Australia Property Index – September Quarterly Update.

To read more please click here.

DeClout to Revive the Pacific Internet Brand; Acquires ISP business from Telstra

19th November 2015, LinkedIn by Selina Lim

For many Singaporeans, Pacific Internet is one of the homegrown heritage brands that we grew up with alongside Singnet and Starhub, when we started to subscribe to internet services two decades ago. I’m sure a number of Singaporeans still hold to the subscription with the domain

Today, DeClout is the proud owner of Pacific Internet. Plans to acquire Pacific Internet took place as early as 2 years ago. Until recently, we managed to ink an agreement with Telstra, Australia’s leading telco company, to acquire both the Singapore and Thai assets and business of this unit. And we have bold plans to revive this heritage brand that all Singaporeans are familiar with through our subsidiary, Acclivis.

To read the full story, please click here

DeClout Asset Acquisitions and Disposals

The board of directors (the “Board”) of DeClout Limited (the “Company”) refers to the Company’s announcements dated 3 November and 18 November 2015 (the “Announcements”) in relation to the proposed acquisition of 75% interests in Play-E Pte Ltd..

Further to Announcements, the Board wishes to announce that the Company has, on 19 November 2015, allotted and issued 24,000,000 new ordinary shares in the capital of the Company, being the DeClout Consideration Shares, to the Vendor and the Guarantor. Following the allotment and issuance of the DeClout consideration shares, the total number of issued and paid-up share capital of the Company has increased from 514,617,530 Shares to 538,617,530 Shares.

The DeClout Consideration Shares shall rank pari passu in all respects with the existing issued Shares.

To read the full announcement, please click here

Analytica User Feedback Shows PeriCoach Improves Sexual Function in Women

November 2015:  Brisbane, Australia

Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System, is pleased to announce that a survey of PeriCoach users also reported increased sexual satisfaction after using the device to treat their stress urinary incontinence.

Analytica recently conducted a survey of customers, and of the 124 respondents 80 reported that that they had poor to average sexual satisfaction before using the PeriCoach, and more than a third reported an improvement in their sexual satisfaction as a result of using the device.

A lack of sexual satisfaction is a condition with significant unmet medical need, with 60.5% of Australian women reporting at least one sexual problem within the preceding year. Other Australian data shows that a lack of interest in having sex was reported by 54.8% of Australian women while 28.6% of respondents were unable to orgasm and 27.3% were not finding sex pleasurable.

“Many women with urinary incontinence face low levels of sexual satisfaction as they may be frightened of leaking or concerned about odour during sex which then affects their mood, libido and levels of satisfaction and arousal” said Dr Pauline Chiarelli, Conjoint Associate Professor and immediate past Program Convener for the Discipline of Physiotherapy at Newcastle University.

“Using the PeriCoach is probably making these women more confident given it is improving their incontinence, and therefore makes them more confident sexually, allowing them to enjoy sex more and become more aroused.”

Analytica Chairman Dr Michael Monsour added that: “This positive feedback from users of PeriCoach underlines the potential for the device to treat a lack of sexual satisfaction in women.  Our user feedback showing an increase in sexual satisfaction in more than a third of women is an enormous market, and all without any side effects.”

To download the full announcement, please click on the link below. 

Proteomics AGM Presentation

20th November 2015, ASX Announcement

2015- An exciting year!

  • Corporate
    - Listed @ 20 cents (April)
    - Options listed @ 1 cent (October)
  • Analytical Services
    - Major contracts in food QC testing and biosimilars (April)
    - WA Exporter of the Year Award [Healthcare] (September)
  • Diagnostics
    - Ground breaking predictive test for diabetic kidney disease (June)
    - Commercialisation agreement for China (February)
    - US and Australian patents granted (September)

To view the full presentation, please click here


Martin Aircraft Completes Latest Phase of Manned Test Flying

20th November 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft) (ASX:MJP) is pleased to announce that it has completed its current phase of manned flight testing of the P12 jetpack.

Over the last six months, the company has been taking the P12 jetpacks through a formal flight testing and evaluation programme which differs from previous testing as these aircraft have been built in more of a production environment, using rigorous build configuration controls and processes.

As a result of the implementation of advanced aircraft sub-systems and better design, the manned flight testing phase has confirmed significant improvements in aircraft handling and maneuverability from earlier flight tests.

To watch a video of the jetpack flight test, please click here.

To read the full announcement, please click here

Launch of New Fund and Debt Facilities from APN Property

19th November 2015, ASX Announcement

APN Property Group Limited (APN) announced today the launch of the APN Convenience Retail Property Fund (the Fund), the Group’ latest unlisted direct property fund.

Forecast to deliver a sustainable distribution yield of 7.20% pa (paid monthly), the Fund’s income is backed by secure long term leases (15 year weighted average lease expiry) to some of Australia’s leading convince retailers including Shell/Viva Energy, Hungry Jack’s, Subway and Masters Home Improvement (guaranteed by Woolworths Limited). The properties, located in Spring Hill, Brisbane and South Nowra, New South Wales, have been acquired under guaranteed delivery contract agreements and are situated in attractive customer demographic and forecast population griwth areas.

To read the full announcement, please click here.  

Altech Chemicals Project Funding Update

19th November 2o15, ASX Announcement


  •  Letter of Interest (LOI) for project financing received from German bank
  • ECA: Interest in senior-debt project financing utilising German export credit insurance cover
  • Highly experienced international project and export finance specialist

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide an update on the progress of financing activities for its proposed high purity alumina project (HPA Project).

Following a series of meetings, a major German bank has submitted a Letter of Interest (LOI), expressing its interest to arrange senior-debt project financing for the Company’s HPA Project. The LOI contemplates senior-debt project financing that will maximise the use of export credit insurance cover under the German federal government backed project finance federal export guarantees.

The bank is a leading German export and project finance specialist with experience in the debt financing of mining and chemical projects worldwide, also in the Asia-Pacific region and projects similar to Altech’s proposed HPA Project.

To read the full announcement, please click here


BPS Technology Chairman’s Address to Shareholders and Shareholder Presentation

18th November 2015, ASX Announcement

Dear Fellow Shareholders, Ladies and Gentlemen, Staff of BPS Technology Limited – welcome to the Company’s first full year results since listing. Technically this is our second AGM but last year’s meeting was reporting on a zero trading period before we actually were listed on the ASX which occurred on 9 September 2014.

The Company and its Management undertook a considerable task in the nine months post September 2014.

The Company did achieve some important key milestones namely:

  • Revenue $48.1 million – slightly below prospectus forecasts due to the delay in the launch of bucqi
  • EBITDA of $10.1 million – exceeding prospectus forecast of $9.9 million driven by a strong performance of Bartercard
  • NPAT $7.9 million - exceeding prospectus forecast of $6.5 million, driven by Bartercard and a more favorable tax outcome
  • EPS 14.88 cents exceeding prospectus forecast of 11.11 cps
  • Full Year Dividend of 5.5 cents per share unfranked

To read the full announcement, please click here

To view the presentation, please click here

Prescient Therapeutics Share Purchase Plan Results

18th November 2015, ASX Announcement

Cancer drug development Prescient Therapeutics Limited (ASX: PTX) has closed its Share Purchase Plan, with strong demand from existing and new investors.

Investors have subscribed for $1,201,500 in new shares, with the price per share to be based on a 20% discount to the 5 day volume weighted average price (VWAP) before the issue date of 23 November 2015.

A final price will be announced on the date of issue of the SPP shares.

PTX advises that the Company is only permitted to accept a maximum of 30% of its current issued capital. In the event that a scale back is required, applications are new shares will be scaled back proportionately

To read the full announcement, please click here.  

Big Review TV Mobile Video App Set for Public Launch

18th November 2015, ASX Announcement


  • Big Review TV consumer mobile app now ready for public launch and patents lodged
  • Successful beta testing completed with positive results achieved and over 26,000 downloads to date
  • Mobile app is expected to drive consumer and member engagement and affords the Company the ability to capture a wider market share
  • Full marketing campaign to promote the app to commence in Q1 2016, expected to substantially accelerate user growth
  • App provides monetisation opportunities as features and in-app purchasing option are introduced

Big Un Limited (ASX:BIG, ‘BRTV’ or ‘the Company’) is pleased to announce its  Big Review TV mobile video app is now ready for public launch.

The app is available to download for free in the Google Play store and Apple’s App Store globally, significantly expanding Big Review TV’s ability to target a wider audience and capture a substantial market share.

To read the full announcement, please click  here

Proteomics International Receives R&D Tax Incentive

18th November 2015, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL)  is pleased to announce it has received an Australian Government R&D Tax Incentive payment of $309,010 for the year ending 30 June 2015.

The Company received the R&D Tax Incentive after spending in excess of $700,000 on R&D activities within its world leading proteomics-focused business in the 2014-15 financial year.

The funds from the R&D Tax Incentive will complement PILL’s existing cash reserves and be used to continue to advance the application and commercialisation of the Company’s products and services derived from its proteomics-based technology platform.

Proteomics is the industrial scale study of the structure and function of proteins and PILL is recognised as a global leader in its field.

To read the full announcement, please click here

Leaf Resources Raises $1.2m from SPP

17th November 2015, ASX Announcement

Leaf Resources shareholders have subscribed for just over 9,400,000 shares at $0.13 raising $1,234,000 for the company in its Share Purchase Plan (SPP) that closed on Friday 13th November 2015.

It should also be noted hat the second tranche of shares under the recent placement to sophisticated investors has settled bringing the total amount raised under the placement to $1,088,471 (before  costs).

To read the full announcement, please click here

OncoSil Medical’s CEO Presents at ASX CEO Session

17th November 2015, ASX Announcement

Developing implantable radiotherapy medical device 

  • 30 micron silicon particles contain beta emitting phosphorous (P32)
  • Safer and stronger medical radiation treatment than external beam radiation

Successfully developed – preparing for EU commercialisation 

  • Four pilot clinical studies completed
    -2 in primary liver/ hepatcellular carcinoma
    -2 in pancreatic cancer
  • Excellent results to support Conformité Européene (CE) Marketing filings for both primary liver and pancreatic cancer & US FDA IDE submission
  • Safety evaluations suggest that OncoSil is well tolerated in patients with unresectable primary liver and pancreatic cancer
  • Efficacy data showed that OncoSil induces significant reduction in tumour volume in both liver and pancreas cancer and significantly reduces pain

To view the full presentation, please click here

SUDA Business Development Update and AGM Presentation

17th November 2015

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it is on track with its business development goals to sign licensing deals in FY2015/16 and to secure philanthropic funding for a second Phase III study of ArTiMist™ in paediatric malaria.

In early November, the management team attended the BIO-Europe international partnering conference, which was held in Munich, Germany; and also the Northern Australian Investment Forum on tropical diseases, which took place in Darwin. These events provided excellent opportunities for the Company to further advance its business development activities.

SUDA’s business development team met with 41 companies at the BIO-Europe event, comprising 24 first-time meetings and 17 ongoing dialogues with prospective partners. The most advanced discussions are at the stage of financial negotiation and span several of the companies’ first-in-class oral sprays in various territories.

To read the full announcement, please click on the link below. 

To view the presentation, please click here.

BPS Appoints Chief Technology Officer

16th November 2015, ASX Announcement

BPS Technology Ltd (ASX:BPS) is pleased to announce the appointment of Mr Andrew McIntyre in the newly created role of Chief Technology Officer, effective 30 November 2015.

Andrew is a strategic thinker with more than 20 years’ experience in a mixture of hands-on, senior management and board roles working in the public and private sectors in both Australia and Internationally. Andrew has demonstrated success in actively leading and enabling the implementation of award winning technology in the business community in senior management roles in both his prior capacity as CIO of the Australian Tourism Data Warehouse “ATDW” and as Director of one of Queensland’s largest credit unions.

To read the full announcement, please click here

Demand for Emmy Winning Shows

13th November 2015, Parrot Analytics

What does global demand look like for Emmy- winning content?

The 67th Emmy Awards was particularly memorable.

With one of the most diverse set of winners in its history, the Emmys recognized some of best content in the industry. This year’s Emmys saw HBO content take the biggest wins, along with some of the best digital originals such as Amazon’s Transparent and Netflix’s Orange is the New Black.

In this article, it noted that when movies won an Oscar (the Emmy equivalent for movies), an increase in box office sales was observed due to an increase in the demand for that movie post-Oscar win. The same article also noted that with Netflix’s 31 nominations and 7 wins at the 66th Emmy awards in 2014, it saw a short-lived increase in its stock. Showcasing that recognition from winning prestigious industry awards such as the Emmys can have a number of positive effects on content businesses, as they are seen as leading providers of great content.

Riding on the buzz of the Emmys, we wanted to investigate the global demand for Emmy-winning content around the world, across platforms. Understanding demand for Emmy-winning content may help when it comes to content acquisition, sales, marketing and advertising. The recognition of quality from an Emmy award could even be the factor that saves a show from being cancelled.

To read the full article, please click here

Bulletproof AGM Chairman’s Address to Shareholders and CEO Presentation

13th November 2015, ASX Announcement

It has been a very busy and successful year for Bulletproof, a year with quality growth as a focus and 2016 should see more of the same.

Highlights since the last AGM on 6 November 2014 include:

  • The acquisition of Pantha Corp (announced 13 Nov 14- Completed 11 Dec 14).
  • Continued strong support from numerous cornerstone shareholders & advisers that supported the ‘listing’ of Bulletproof on 2 Jan 14 and subsequent activities.
  • Strong FY15 financial results delivering ongoing shareholder value.
  •  Following the acquisition of Panthacorp in December 2014, provision of an end to end cloud services offering to existing and new clients.
  • The acquisition of Infoplex Pty Ltd (announced 16 Sept 15 – completed 8 Oct 15) building on existing Bulletproof leading private cloud capability and bringing a number of new enterprise clients.
  • Placement to institutions raising $3.8million at 25 cent per share (23 Sept 25)
  • Share Purchase Plan (SPP) to eligible shareholders raising $3.5million at 25 cents per share (details announced 5 Oct 15 and completed 30 Oct 15)

To read the full announcement, please click here

To view the presentation, please click here

TFS AGM 2015 Presentation and Chairman’s Address

13th November 2015, ASX Announcement

When I reflect on the last 12 months at TFS, I am extremely pleased that the Company has either delivered on or exceeded its expectations for the year. During my first address to you here 12 months ago, I outlined three key opportunities we would target to grow TFS, in line with our ‘soil to oil’ strategy. These were:

  • Firstly, increasing the amount of TFS-owned sandalwood plantations;
  •  Secondly, controlling more of the value chain; and
  • Thirdly, working with end market participants to establish high value uses and increased sales of our oil.

This growth strategy was supported by our strong market position through our pharmaceutical grade sandalwood oil; high barriers to entry; and sustainably high demand from from a broad range of end markets, including the pharmaceutical, fragrance, cosmetic and traditional markets.

Firstly, TFS increased the amount of Indian sandalwood plantation estate it owns by 10 per cent to 3,493 hectares, or approximately one-third of the total estate. Importantly, the total estate grew  by 16 per cent to 10,583 hectares after TFS completed more than 1,500 hectares of new plantings in the year. To put this into context, approximately 4.5 million Indian sandalwood trees are growing in plantations owned or managed by TFS across Western Australia, the Northern Territory,  and northern Queensland. This estate now has an audited value of nearly $2 billion. This scale truly demonstrates our leading position in the market.

To read the full announcement, please click here

To view the presentation, please click here

Nick Chan Appointed as TopBetta’s New Chairman

16th November 2015, The Australian by Jake Mitchell

Chan was speaking to Media about his new role as chairman of online wagering business TopBetta, which is aiming to list on the ASX next month.

Chan’s role at TopBetta, which is advised by Foster Stockbroking, is a change of pace for the long-time traditional media executive.

TopBetta is a gaming website that focuses on tournament betting, which is its key point of differentiation from the big betting sites, such as William Hill Australia, Ladbrokes and Sportsbet.

To read the full story, please click here

Kube Systems Portable Smartphone Chargers Now in New York Hotels

Kube Systems is presenting its portable smartphone charging devices at America’s largest hotel trade show in New York City this week.  Over 130 hotels around the world are already using Kube Systems, including the New York Marriott Marquis with over 30 KS Portable charging units at A$2,500 each.

Each KS Portable is equipped with a charger for Apple® Lightning, Apple® 30-pin, and micro-USB flip-out cable. The Kube also boasts two additional USB ports and topside Qi wireless charging. Each charge provides up to nine hours of phone charge time.

Kube chargers in hospitality venues are designed to exceed guests’ expectations, increase satisfaction and drive loyalty.

Kube Systems makes portable smartphone wireless charging units for worldwide hospitality industry.  The aim of the capital raising is to connect the units to Internet of Things, develop data analytics from customers charging phones and advertise on screens of each unit.

  • Year 1: $2.4m sales, $450k unaudited profit.
  • Oct 2015: $324,000 from US and UK distributors.
  • 6 distributors worldwide.
  • Key customers: Marriott, Starwood, Four Seasons.
  • Pipeline: Disney (2nd meeting), Intel (NDA signed).
  • International PCT patent filed.
  • Seeking: $3m on $7m pre-money valuation.
  • Similar VC-backed co:

Kube Systems is seeking $3m from sophisticated investors to develop the next generation of IoT portable chargers and to roll out the product around the world.

YuuZoo Expands From Master to Vertical Franchisees, Sells Sports Franchise for the United Kingdom

12th November 2015, YuuZoo Corporation

  • In order to increase focus of its franchisee operations, YuuZoo adds football franchisees to its franchise model
  • Company sells a sports franchise for the UK for US$13.3 million
  • Franchise agreement targets 5.4 million new users to be part of the YuuZoo platform within 36 months

Singapore Exchange listed YuuZoo Corporation Limited (“YuuZoo” SGX: AFC.SI), one of the world’s fastest growing third generation social e-commerce networks, has strengthened its presence in the United Kingdom by selling its first franchisee for the football sector.  RM Powershot Challenge (“RPC”), a company with a firm foothold in football in the UK, has agreed to buy the UK sport franchise from YuuZoo in a share based deal valued at US$13.3 million. In line with YuuZoo’s revenue recognition policy, only half of this will initially be recognised, with the other half recognised if the franchisee reaches the agreed first 12 month targets.

The CEO of RPC, Sverker Siren has a strong track record of negotiating and signing deals with leading football clubs, monetising their fan base through mobile games. RPC already has agreements with 2015 EPL champion Chelsea FC, 2014 EPL champion Manchester City, 46-time Scottish champion Glasgow Celtic, 18-time England football champion Liverpool FC, and 12-time English FA Cup winner Arsenal FC. While the franchise initially will focus on the football segment, RPC also aims to expand into other sports such as cricket and rugby.

A key focus for the franchisee will be to sell the concept of “virtual clubhouses” to UK football clubs. In the virtual clubhouses fans can purchase fan merchandise, interact with other fans and club representatives, download and play games, share and view photos and videos, and where applicable, engage in online betting. The revenues from all these activities will be shared between the franchisee and YuuZoo.

To read the full announcement, please click here


Charter Hall AGM Presentation 2015 and Chair’s Address

12th November 2015, ASX Announcement

This year marks Charter Hall’s 10 year anniversary since listing on the Australian Securities Exchange, a period which has seen us evolve into a leading ASX 200 listed property investment and management business.

Our proven strategy remains focused on utilising our property expertise to access, deploy, manage and invest equity in our core real estate sectors to create value and generate superior returns for our customers.

Today we manage a $14.8 billion high quality portfolio of office, retail, industrial and hospitality assets servicing close to 3,000 tenants on behalf of wholesale, listed and retail investors with the goal of becoming Australia’s most highly regarded property investment and funds management business.

To read the full announcement, please click here

Folkestone Pursues Seniors Living Platform

Folkestone announced today it intends to pursue the development of a Seniors Living platform which will include retirement villages and aged care facilities.

To develop this arm of our Social Infrastructure business, Stuart Nicolson, previously CEO of Retirement Alliance until its sale in January of this year has accepted the position of CEO – Seniors Living.

Mr Nicolson brings 10 years’ experience in the seniors living area and was instrumental in building the Retirement Alliance business which owned and managed senior living assets worth more than $700 million. Mr Nicolson was also a director of the Retirement Living Council between 2008 and 2015, the industry’s peak body for the retirement industry.

Mr Greg Paramor, Managing Director said “We are delighted that Stuart has joined Folkestone to drive our move into the senior’s living space. The demographic trends are compelling, and at the same time, there is significant demand for high quality seniors living accommodation. We believe that the move into seniors living is a natural extension of our strategy to be a key player in the social infrastructure space. We already have more than $750 million in funds under management in social infrastructure through the ASX listed Folkestone Education Trust, Australia’s largest owner of early learning properties, and the unlisted CIB Fund which owns police stations and courthouses in Victoria.”

Mr Nicolson said “the seniors’ living space continues to evolve to meet the needs of an ageing population. I look forward to working with the Folkestone team to develop a platform that will offer a range of seniors living opportunities for the community and which will provide investment and development opportunities for both its funds management platform and balance sheet.”

CNMC Financial Statements And Presentation Slides

11th November 2015, CNMC

  • Fine gold production increased 8.3% to all-time high of 8,305 ounces
  • All-in cost of production fell 13% to US$564 per ounce of gold
  • Revenue slipped 1% to US$9.9M as higher output partly offset by lower selling price
  • As at end-3Q 2015, cash pile almost doubled to US$18.3M from US$9.4M as at end-3Q2014

CNMC Goldmine Holdings Limited (“CNMC” or “the Company”) announced today that it produced and sold a record 8,304.67 ounces of fine gold in the three months ended 30 September 2015 (“3Q2015”), up 8.3% from the same period last year (“3Q2014”).

The increased output enabled the SGX Catalist-listed miner to weather the decline in gold prices during the quarter. Revenue was marginally down 1% at US$9.95 million compared to US$10.05 million in 3Q2014.

CNMC, which operates a gold mine in the Malaysian state of Kelantan, also reported an improvement in production costs in 3Q2015. Its all-in cost of production for every ounce of gold sold declined 13% from US$648 to US$564 in 3Q2015, reflecting the success of its ongoing efforts to improve operational efficiency.

To read the full announcement, please click here.

To view the Presentation Slides please click here

Motim Technologies Achieves Investment Target

Motim Technologies Limited has now achieved its investment target and is in over-subscription with its investment round scheduled to close at 10pm (NZT) on Wednesday 11 November 2015. Motim is a creative software technology company that works internationally with global brands, and is preparing to launch its new mobile SaaS platform early in 2016.


Motim Technologies is a mobile software technology company that has been innovating in mobile marketing technology since 2007, providing creative technology for leading global brands and their advertising agencies that consumers choose to engage with, creating positive brand engagement that doesn’t feel like advertising.

To launch its SaaS platform in the USA and position the company for subsequent rapid expansion, Motim is seeking up to NZ$1,500,000 (24.1% of equity).

BPS Technology Investor Update

10th Novemeber 2015, ASX Announcement

BPS Technology Limited (ASX: BPS) presented at the inagural TechKnow Invest Roadshow on the Gold Coast, in Sydney and Melbourne.

Please see our website for the video of the presentation (click to start) delivered by Trevor Dietz, CEO of BPS.

BPS has also been included in the highly anticipated second edition of the DJ Carmichael’s research titled Emerging ASX Technology Sector, please see our website here to view the document.

To read the full announcement, please click here

Martin Aircraft Signs MOU With Dubai Civil Defence

10th November 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft) (ASX:MJP) is pleased to announce that it has signed a Memorandum of  Understanding (MoU) with the Directorate of Civil Defense for the intended future delivery of manned and unmanned Jetpacks, Simulators, Spares Parts, Support Services and both Pilot and Engineer training for appropriate Civil Defense and Fire Service personnel.

The agreement was signed on 9 November 2015 at the Dubai Air Show and marks a significant step forward for the advanced delivery of first responder services in the United Arab Emirates.

The signing ceremony at the Dubai Air Show was attended by Lt Col Expert Ali Hassan Almutawa, Director Operations on behalf of Major General Rashid Thani Al Matroushi, Director-General of Civil Defense and senior representatives of both the New Zealand and Dubai Government, along with the Chief Executive Officer/Managing Director of Martin Aircraft Company Mr Peter Coker.

To read the full announcement, please click here


Leaf Resources Voted #32 in Hottest Small Companies in Advanced Bioeconomy

9th November 2015, ASX Announcement

Leaf Resources continues to build its reputation, position and profile in the world Bioeconomy with our latest success announced in the USA. At the Advanced Bioeconomy Leaders Conference held in San Francisco, Leaf Resources was voted number 32 in the 2015-16 “40 Hottest Smaller Companies in the Advanced Bioeconomy” rankings, published by The Digest, the world’s most widely-read advanced Bioeconomy daily.

The Hot 40 recognizes companies with less than 100 full-time employees and $20 million or less in annual revenues. The rankings recognize innovation and achievement in biobased chemicals, materials and fuels by emerging companies, and are based 50 percent on votes from an invited panel of distinguished international selectors and 50 percent on votes from subscribers of The Digest.

The Miami, FL-based Digest serves more than 1,800,000 unique readers and followers via the web, newsletters, social media and broadcast in every UN-recognized country. Over 190 companies from around the world were included in the vote.

To read the full announcement, please click here

Prescient Therapeutics Shareholder Newsletter

9th November 2015, ASX Announcement

Prescient Therapeutics Limited (ASX: PTX), a clinical stage oncology, provides the following market update via a shareholder newsletter.

PTX is a clinical stage oncology company developing novel compounds that show great promise as potential new technologies to treat a range of cancers that have become resistant to front line chemotherapy.

Lead drug candidate PTX-200 inhibits an important tumor survival pathway known as AKT, which plays a key role in the development of many cancers, including breast and ovarian cancer, as well as leukemia. The highly promising compound is now the focus of two current clinical trials. The first is a Phase 1b/2 study examining PTX-200 in breast cancer patients at the prestigious Montefiore Cancer Centre in New York. A Phase 1b/2 trial of the compound in combination with current standard of care is also underway in patients with recurrent or persistent platinum ovarian cancer at Florida’s H. Lee Moffitt Cancer Centre. These trials are funded in part by grants from  the U.S. National Cancer Institute. In addition, PTX is planning a Phase 1b/2 trial evaluating PTX-200 as a new therapy for acute myeloid leukemia.

To read the full story, please click here.  

REA Group Bids for Catcha Group’s iProperty

Grove hits it out of the park with REA-iProperty merger

Digital News Asia
AUSTRALIAN-based REA Group, which is 60%-owned by Rupert Murdoch’s News Corp, is making a bid to completely take over Malaysian-founded property portal company, iProperty Group, which is listed on the Australian Securities Exchange (ASX).
Describing the proposed deal as a “global game-changer” from a property sector point of view, on a personal level, Catcha Group Sdn Bhd founder and chairman Patrick Grove is also keen to stress his hopes that his latest deal “inspires other entrepreneurs to start great disruptive companies.”
Read more 

iflix Group CEO, Mark Britt presents an overview of OTT at CASBAA Convention 2015.

CASBAA is one of the content industry’s most important events in Asia. This year’s theme, ’Making Waves’ focused on on innovation and the realities of convergence in the rapidly changing industry with the introduction of online, on-demand, and TV Everywhere services. 
play video


Catch CEO Update 
It has been an eventful month for Catcha Group companies, with many exciting developments coming to fruition, most notably REA’s bid for one of our most important assets. iProperty. We are very proud to be a part of the company’s inspiring journey from its humble startup beginnings to becoming the region’s leading network of property portals in just eight years since its inception. iflix, the newest member of the Catcha family, continues to cement its position as Southeast Asia’s leading Internet TV service, setting new subscriber and viewership records, as we look to launch in 10 new markets globally within the coming 6 months. Exciting times ahead!

Leaf Resources Latest Newsletter November

Biofuels Digest Hottest 40 Leaf Resources Voted #32

The Digest’s 40 Hottest Small Companies in the Advanced Bioeconomy for 2015-2016 has recognised Leaf Resources as one of the hottest companies in this field. The awards were held in San Francisco, on the 3 October. Read more>>

To see who made the 40 Hottest Small Companies in the Advanced Bioeconomy List click here>>

The Pursuit of Low-Cost Cellulosic Sugars

Biofuels Digest Review
Leaf Resources recently featured in the Biofuels Digest. Discover our 8 slide guide to transforming biomass into clean, cellulosic sugars here>>

US Corporations make pledge on climate change

81 Companies Sign Amercian Business Act on Climate Change
In Washington, 81 major corporations with operations in the U.S.–including Google, Facebook, Apple, Coca Cola and General Motors–have taken a White House pledge “to demonstrate their support for action on climate change and the conclusion of a climate change agreement in Paris that takes a strong step forward toward a low-carbon, sustainable future.” Read the full article here>>

Leaf raises Capital to progress Glycell Development

Leaf Resources recently announced that it has raised a further $1M to continue the development and comercialisation of the GlycellTM process. Read the announcement >>

Wholesale Investor London Emerging Company Showcase

On the 5th of November 2015 Leaf Resources participated in the Wholesale Investor Emerging Company Showcase at the Edison Investment Research Offices in London.
To find out more about the event click here >>

Looking to find out more about Edison Investmenclick here>>


Booodl Featured in the App Store!

I wanted to share something exciting: Booodl has been featured in the App Store “Shopping” category! We couldn’t have asked for a better boost in the lead-up to our official launch later this month. We just posted the good news on Facebook and it would be amazing if you could help us get the word out by sharing.

In other news, our Inside Booodl video this week looks at loyalty programs: one area of retail that’s definitely due for a shake up! Getting your 10th coffee free simply doesn’t cut it anymore; consumers are too smart. The brands that do it best offer immersive and personalised experiences. In this video I share who they are and what they’re doing. You can also read the original post in full on LinkedIn.


Kube Systems November Update

Kube Systems Announces Apple Watch Charging Device

Kube Systems has just announced a new device that charges Apple Watches.

Now Kube portable charging units and bedside units charge not only every smartphone on the market, but also Apple’s latest “must-have” accessory.

The Apple Watch charging arms are designed specifically for the needs of hotel guests and restaurant patrons.  As more customers start to wear their Apple watches, they will be forced to stuff yet another cable into their bags because this new device needs to be charged once a day.  So now it will be an additional Magsafe charger fighting for space in those already crowded carry-ons.

That is, unless the venues have Kube Systems chargers with Apple Arms.  Kube Systems products deliver the charging power that guests need throughout hotel and restaurant properties.  Kube Systems integrates wired and wireless charging technologies – and now Apple Watch chargers.

Kube Systems

Kube Systems is the smart phone recharging solution for the worldwide hospitality industry.

Hospitality is competitive. Hotels, bars and restaurants have to build customer engagement and drive revenue from people who travel and dine out.

The problem is that these customers’ devices go flat in the venues, leading to customer anxiety, a diminished customer experience and loss of revenue when customers leave the venue to charge their devices.

Kube offers a solution:

  • For bars and restaurants, a universal charging unit that charges up to six devices on the bar or at patrons’ tables.
  • For hotel rooms, a combined universal charging device and alarm clock that charges up to six devices on the bedside table.

Now, bars and restaurants can provide patrons relief from the anxiety of a device that is about to go flat, whilst encouraging them to spend more as their devices charge.  Hotels can drive customer engagement by letting guests charge multiple devices from the one unit instead of having to unplug lights and move furniture to find a power outlet.

Kube is raising capital to fund its next generation of phone charging units with the aim of developing targeted local advertising and integrating the units into the Internet of Things.

The product/market fit has been validated with:

  • A$2.3m in orders since launching in August 2014.
  • Distributors in US, Europe, UK, Asia Pacific, India and the UAE.
  • Marriott Hotels as a flagship customer.

Kube Systems has:

  • A PCT patent application,
  • A founder with “preferred supplier” status with Marriott Hotels, and
  • A signed an NDA with Intel.

The Company plans to roll out its products in the B2B hospitality market in the US, Europe and Asia Pacific.

Kube is seeking $3M in first round funding from qualified investors to hire a bigger sales team, fund inventory and accelerate its Internet of Things product development.

Folkestone Real Estate IQ Introduces Real Estate Performance at Your Fingertips

9th November 2015

Folkestone is pleased to provide you with a new addition to its Real Estate IQ website, Real Estate PerformanceReal Estate Performance provides a snapshot of the performance of the  three Real Estate Sectors - A-REITs (monthly), Residential (monthly), and Non-Residential (quarterly) markets. We are mindful that most of us are time-poor, so we have summarised the key performance information in easy to view graphical flyers. Click here to download your copy.


Real Estate IQ provides our latest thinking on real estate to assist you in navigating the world of real estate investing, allowing you to make more informed investment decisions.

You will find leading edge educational pieces about real estate investing in our White Papers, our views on real estate markets in Market Views, our News Articles section includes articles from various publications that Folkestone staff have written or been quoted in, and our Videos feature Folkestone staff discussing trends in real estate investing. With one click our Best of the Web section puts you in touch with interesting papers and presentations on real estate investing that we have found on the web, while our Blog provides our latest thoughts on a range of topics and creates a forum for conversation.Real Estate Performance provides a snap shot of the performance of the three Real Estate Sectors – A­-REITs, Residential and Non-Residential.

Click here to visit Real Estate IQ and click here to register to receive our research reports and Blogs.


The Folkestone Maxim A-REIT Securities Fund is a high conviction, actively managed, unlisted, registered, managed investment scheme that gives investors exposure to a mix of quality listed A-REITs, which own assets across the retail, residential, commercial, hotel, industrial and real estate related social infrastructure sectors. The Folkestone Maxim A-REIT Securities Fund was the best performing fund in the Morningstar Australian Institutional Sector Survey to 30 June 2015 with a total return of 21.4% (pre-fees and tax).  Click here for more information on the Fund.            

Avenir Capital October 2015: +6.2%

The Avenir Value Fund returned +6.2% net of all fees and expenses in October 2015.

                            Net Return*
Calendar YTD:                                            8.1%
Trailing 12-months:                                     2.9%
Cumulative return since inception:           76.2%
Annualised return since inception:           14.3%
* Net of all fees and expenses

Please click this link to view the Avenir Capital October 2015 Performance Update.

In October we welcomed on board the Future Generation Global Investment Company and we are pleased and honoured to be able to contribute to this initiative.

If you would like to discuss how Avenir Capital can complement your investment portfolio, please do not hesitate to contact us.

YPB Signs New Deal for ePassport Technology

6th November 2015, ASX Announcement

  • YPB’s VariSec technology to be applied to further 1.5 million ePassports
  • Growing acceptance of YPB technology in new economies

Brand protection solution company YPB Group Limited (ASX: YPB) has been contracted to provide its proprietary VariSec technology to a significant Southern African country. The news comes after YPB was recently contracted by a major first world economy to supply the proprietary VariSec technology for application in 15 million ePassports.

This new order substantially increases YPB’s penetration into the world of securing ePassports globally.

The technology was developed by YPB’s recently acquired subsidiary Intellectual Product Protection (IPP) and receipt of the order is seen as a further validation of the purchase of the business.

To read the full announcement, please click here

ISEC Healthcare Ltd – Financial Statements and Third Quarter Results

ISEC Healthcare Ltd. (the “Company”) was listed on Catalist of the Singapore Exchange Securities Trading Limited (the “SGX-ST “) on 28 October 2014. The initial public offering of the Company (the “IPO”) was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor ” or “PPCF”).

This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor for compliance with the SGX-ST Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX- ST assume no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Keng Yeng Pheng, Associate Director, Continuing Sponsorship, at 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, telephone (65) 6229 8088.


ISEC Healthcare Ltd. (the “Company”) was incorporated in the Republic of Singapore on 2 January 2014 under the Companies Act (Chapter 50) of Singapore as a private limited company. The Company and its subsidiaries (the “Group”) were formed pursuant to a restructuring exercise (the “Restructuring Exercise”) prior to listing on the Catalist of the SGX-ST on 28 October 2014. Please refer to the Company’s offer document dated 14 October 2014 for further details on the Restructuring Exercise.

On 22 September 2014, ISEC Eye Pte. Ltd. (“ISEC Eye”) (which was a standalone entity then) acquired the entire businesses of Lee HM & Co Pte. Ltd., Singapore Lasik Hub Pte. Ltd., Perfect Vision Eye Centre Pte. Ltd. and Lee Hung Ming Eye Centre Pte. Ltd. (collectively, “LHM Companies”), each wholly-owned by Dr Lee Hung Ming, as part of the Restructuring Exercise to streamline the Group’s business operations.

On 26 September 2014, the Company completed the acquisition of the entire issued and paid up share capital of ISEC Sdn. Bhd. and its subsidiaries, by way of pooling-of-interest, and ISEC Eye, by way of acquisition accounting. Accordingly, ISEC Eye became a wholly-owned subsidiary of the Company and the Group consolidated the results of ISEC Eye with effect from 26 September 2014.

To download the full document, please click ion the link below. 

New European Patents for Opal Biosciences Antimicrobial, BDM-I

5th November 2015, BioDiem

BioDiem Ltd is pleased to announce that the European patent office has granted two new divisional patents for BDM-I use in two areas of infection:

  • Enteric or gut infections caused by the bacteria Clostridium perfringens,Clostridium difficileSalmonella typhimurium, Salmonella paratyphi, Campylobacter, Shigella variant spp., Bacteroides and Bacillus subtilis; and the yeast, Candida albicans; and
  • Other infections such as systemic and respiratory infections caused by many bacteria including methicillin-resistant Staph aureus (Golden Staph) and Strep pyogenesStrep epidermidisHaemophilus influenza which can cause serious infections.

To read more, please click here

Investor Presentation and a Trading Update from Crowd Mobile

4th November 2015, ASX Announcement

Crowd Mobile Limited (ASX : CM8 & FWB-XERTRA: CM3) is pleased to announce an update on its operations for the quarter ending 30th October 2015.

Key highlights for the three months trading to 30th September 2015 include:

  • Strong growth in the number of billed messages achieving 108% PCP growth a 12% quarter on quarter growth
  • Expanded product and content offering with the launch of new apps, m-commerce services and the execution of an exclusive licensing agreement with AdsMetric
  • Post balance date the Track Concepts acquisition was completed, along with the associated debt & equity capital raising to fund the acquisition
  • The combined group now operates in 50 countries, is connected to over 150 mobile carriers and provides products in over 30 languages

To read the full announcement, please click here

To view the Investor Presentation, please click here

Bulletproof Share Purchase Plan Over-Subscribed

4th November 2015, ASX Announcement

Bulletproof Group Limited (ASX: BPF) is pleased to announce that the offer to eligible shareholders to participate in a share purchase plan (SPP) announced on 16 September 2015, has been completed with strong demand resulting in applications for three times the expected take-up. The plan was announced with an offer price of $0.25 per share, the same price as the institutional placement that was used to fund the acquisition of Infoplex Pty Ltd. A waiver from the ASX was granted under listing rule 7.1 to allow an offer price at a 22.6% discount  to the 5-day VWAP prior to the offer being announced.

The Company advises that applications will be scaled back equally by around 24% to arrive at a final total of $3.5m, some 2.3x the initially expected take-up.

To read the full announcement, please click here

New Investor Presentation from Prescient Therapeutics

4th November 2015, ASX Announcement

Prescient Therapeutics have today released a new Investor Presentation. which can be viewed by clicking here.


Prescient Therapeutics (formerly Virax Holdings) is a clinical stage oncology company developing novel targeted approaches to treat cancers of high unmet need, such as advanced breast, ovarian, multiple myeloma and acute leukemia.

The company raised A$3M in June 2014 and has in the last 6-months acquired a deep pipeline of products through strategic company acquisitions. Prescients’ pipeline includes a small molecule inhibitor PTX-100 (GGTI 2418), capable of blocking the Ras cancer pathway as well as PTX-200 (TCN-P) which inhibits the AKT pathway, another key pathway that contributes to cancer.

Together these novel drugs provide Prescient the unique ability to run five active clinical trials, within the next 12-months, at some of the worlds best Cancer Centers. The aim is to bring to provide better outcomes for cancer patients around the world.

SUDA Invited To Northern Australia Investment Forum

3rd November 2015, ASX Announcement

SUDA Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, today announces that Mr. Stephen Carter, Chief Executive Officer and Managing Director, has been invited by Hon. Andrew Robb, Minister for Trade and Investment, to attend the Northern Australia Investment Forum, being held in Darwin, Australia from 8 to 10 November 2015.

The forum is a high-level, invitation-only event. The Minister has invited senior executives from leading international companies and global health philanthropies who are interested to understand better the diversity and scale of Australian research into tropical diseases. Mr. Carter has been invited to promote investment opportunities regarding SUDA’s novel anti-malarial sublingual spray, ArTiMistTM.

To read the full announcement, please click here

Martin Jetpack Director Appointment

2nd November 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft) (ASX: MJP) advises that Dennis Chapman has been appointed as a director, effective immediately.

Dennis has been appointed by the Board as an additional director to ensure the Company complies with its New Zealand director constitution residency requirements. Dennis was previously a director of Martin Aircraft from 2 July 2010 to 11 July 2014.

The board of the Company welcomes Dennis back to Martin Aircraft.

To read the full announcement, please click here

Atomo Diagnostics Awarded ‘Innovation in Export’ Award at Premier’s NSW Export Awards 2015

October 28th 2015

Atomo Diagnostics is delighted to announce that the company received the ‘Innovation in Export’ Award at the 2015 Premier’s NSW Export Awards, hosted by the Export Council of Australia

The award recognises a NSW company that has made innovation an integral part of their exporting process. Atomo currently exports its rapid test products AtomoRapid™ HIV and AtomoRapid™ Malaria to Africa, where the company works with both private sector clients as well as leading NGO’s and public health agencies to ensure that its products can be used in resource limited settings where these diseases have the highest burden.

Atomo also exports its award winning AtomoRapid™ technology to Europe where it is utilised by other diagnostic companies looking to upgrade their product offerings and provide solutions that deliver improved usability, safety and convenience.

“This achievement for a young company is testament to the hard work our team has put in to build a world-class company commercialising innovative and disruptive diagnostic technology globally,” says John Kelly, CEO of Atomo Diagnostics.

John Kelly said after receiving the award, “Given the types of products we develop and the relatively small size of the Australian market, it is imperative for us to be export focused. Having our design and development and corporate activities located within Sydney, NSW allows us to attract top talent from around the globe and use this as a base to support our innovative global export strategy targeting both global health and developed healthcare markets. Without the support of the Export Council of Australia, this would not be possible.”

To download the full document, please click on the link below. 

Altech Finalises Kaolin Mining Rights Agreement with Dana

30th October 2015, ASX Announcement 


  • Altech grants Dana the exclusive right to mine up to 10Mt of kaolin for a $1m cash payment
  • Dana may increase its kaolin mining right to 30Mt by paying an additional $2m
  • Altech will also receive a 2% gross sales royalty on all bulk kaolin sales
  • Currently kaolin resources at Meckering are estimated at 65Mt
  • Altech’s HPA project requires only 4Mt of kaolin for a 100 year project life

Altech Chemicals Limited (Altech/ the Company) (ASX: ATC) advises that it has reached agreement with Dana Shipping and Trading S.A. (Dana) to grant Dana the exclusive right to mine up to 10Mt of kaolin from the Company’s Meckering kaolin deposit. The Meckering Deposit covers approximately 184km2 in area and contains indicated and inferred kaolin mineral resources estimated at 64Mt @ 83.4% brightness JORC (2004).

To read the full announcement, please click here

Crowd Mobile Complete Track Acquisition

30th October 2015, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to advise that its acquisition of 100% of the share capital in Track Holdings B.V (Track Acquisition) has been completed. As a result, Track Holdings B.V is now a wholly-owned subsidary of Crowd Mobile, and forms part of the Crowd Mobile group of companies.

As part consideration for the Track Acquisition, the Company has issued shares in Crowd Mobile to the vendors of Track Holdings B.V. The shares are subject to voluntary escrow for a period of 12 months from their date of issue. Crowd Mobile will apply for quotation of the consideration Shares in the Appendix 3B to follow shortly.

To read the full announcement, please click here.    

Big Review TV Limited’s Annual Report to shareholders

30th October 2015, ASX Announcement

Big Review TV Limited’s core business is the production of video reviews for businesses, of businesses. Its professionally produced and edited video reviews are targeted at small-medium sized business customers who do not otherwise have access to such services at a reasonable cost. Big Review TV Limited also provides the technology and capability for consumers to post self-generated video reviews of their experiences and provide feedback, making it an  end-to-end review service.

The Company’s unique business model enable sit to produce videos significantly below the cost of traditional media products. Each business then has the opportunity to apply for an annual membership to the platform, publishing their video on the platform and promoting their business to those searching the Big Review TV database.

To read the full announcement, please click here

Altech Chemicals Quarterly Activities and Cashflow Report

30th October 2015, ASX Announcement

  • $1.3 Million share placement for detailed design of High Purity Alumina plant
  • Agreement signed with Mitsubishi Australia Ltd for High Purity Alumina sales into the Japanese market
  • Malaysian diversified industrial group Melewar IIC Limited joins the Company as a strategic shareholder with an initial investment of $1.0 million
  • Company’s board expanded to include Prince Ya’cob bin Tunku Tan Sri Abdullah as a non-executive director
  • Land for the Company’s proposed High Purity Alumina plant secured in the Tanjung Langsat Industrial Complex, Johor, Malaysia
  • Permitting for Meckering kaolin mining operations commenced
  • Experienced chemicals industry operations executive Dr Jingyuan Liu appointed as General Manager Operations
  • Annual General Meeting completed with all resolution carried

Altech Chemicals Limited (Altech/ the Company) (ASX: ATC) presents the quarterly activity report for the three months ended 30 September 2015.

In early August, 2015, the Company announced that it had raised $1.13 million vioa share placement for the commencement of detailed design work for its proposed high purity alumnia (HPA) project and for corporate and general working capital purposes.

To read the full announcement, please click here.  

Global Print & Packaging Partnership for YPB

29 October 2015, ASX Announcement

  • YPB signs Memorandum of Co-operation with global Company in supply chain management, print and packaging solutions
  • Elanders has supply chain management, print and packaging operations in 15 countries worldwide
  • Immediate global brand access for all elements of YPB technology
  • Huge endorsement for YPB’s Brand Protection solution

Brand Protection technology company YPB group Limited (ASX:YPB) has a signed a Memorandum of Co-operation (“MOC”) with Elanders Beijing Printing Co. Ltd (“Elanders”), the Chinese subsidiary of the Stockholm, Sweden, listed global supply chain, print & packaging and e-commerce company Elanders AB (publ) , (SS: ELAN)

The MOC, which is for a period of three (3) years, will see Elanders offering exclusively YPB Brand Protection and product authentication solutions to its customers across Pan Asia and YPB working exclusively with Elanders for printed packaging, brand protection and product authentication solutions across the region.

To read the full announcement, please click here

iFAST Reports Year-on-Year Increase of 21.3%

29  October  2015, iFast Corporation

Healthy year-to-date growth in net profit, but net profit in 3Q2015 fell 0.5% YoY to S$2.95 million given the poor market conditions

  • Net profit rose 21.3%YoY in 9M2015 to S$9.24 million
  • Net revenue rose 1.9% YoY to S$10.14 million in 3Q2015 and 14.8% YoY in 9M2015 to S$31.38 million respectively
  • Net sales in 3Q2015 stood at S$46 million and contributed positively to Assets under Administration (AUA), but the sell-off in global markets negatively affected the valuation of the Group’s investment products
  • AUA rose 5.5% YoY to S$5.42 billion as at 30 September 2015, but declined compared to the 30 June 2015 level of S$5.71 billion due to the sell-off in global markets
  • The Group’s wholly-owned China subsidiary was awarded a Funds Distributor Qualification from China Securities Regulatory Commission (CSRC) on 19 October 2015

In 3Q2015, the Group reported a YoY decrease of 0.5% in its net profit to S$2.95 million, while net revenue rose 1.9% YoY to S$10.14 million. Year-to-date to 30 September 2015 (9M2015), the Group’s net profit rose 21.3% YoY to S$9.24 million, while net revenue rose 14.8% YoY to S$31.38 million.

AUA rose 5.5% YoY to S$5.42 billion as at 30 September 2015, but declined compared to the 30 June 2015 level of S$5.71 billion. Net sales in 3Q2015 stood at S$46 million and contributed positively to AUA, but the sell-off in global markets negatively affected the valuation of the Group’s investment products.

To read the full announcement, please click here

Analytica Quarterly Cash Flow

Appendix 4C – Quaterly Cash Flow Report

nalytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System, today released its Appendix 4C – Quarterly Cashflow report for the period ended 30 September 2015. The cash balance at 30 September 2015 was $1,533k. PeriCoach® is a novel medical device to treat stress urinary incontinence – a condition with significant unmet medical need, affecting one in three women worldwide.


  • Successful capital raising of $2.9m
  • Lodged 2015 R&D tax credit and expect receipt of $1.9m in November
  • Continued sales growth $84k
  • Continued progress with R&D for PeriCoach® $402k
  • Marketing and Sales launch in US including conference and social media US & Aust. $614k
  • Agreement with SalesForce4Hire to grow sales of PeriCoach® in the US
  • US distribution agreement signed
  • Increased sites and participants in the on-going clinical trial
  • Appointment of Dr Thomas Lönngren as Non-Executive Director

During the quarter, Analytica made progress in its sales and marketing activities for its lead product, the PeriCoach® System, and the cash balance of $1,533k supports these activities as well as continued R&D efforts for further enhancements of PeriCoach®.

In August, the Company conducted a successful capital raising of $2.9m, with the proceeds being used to support Analytica’s key commercialisation goals for PeriCoach®.

The Company achieved key milestones with US sales and marking efforts in the quarter with the signing of a services agreement with SalesForce4Hire. SalesForce4Hire is a leading US commercialisation company and the agreement will help drive sales of PeriCoach® in the US market. The sales team commenced on October 1 and will focus on three US regions.

Analytica has a distribution agreement with US-based Current Technology Inc, a specialist distribution partner. Current Technology wholesale purchase PeriCoach® units and engage in marketing and sales activities across its extensive network, enhancing Analytica’s own US-based distribution efforts.

In addition, the “Leakers Anonymous” video was launched as part of Analytica’s US social media strategy and the campaign placed the video in front of 5.5 million blog subscribers, 250,000 Facebook followers and 170,000 Twitter followers.

PeriCoach® has continued to exhibit at major US and international urology and gynecology conferences and the response from specialists has been very supportive.

In Australia, sales continue to increase as we continue our direct-to-consumer and top-down marketing approach of building awareness of the PeriCoach® System as an effective medical device with general practitioners and health professionals.

Meanwhile, in our clinical trial being conducted in Australia, more trial sites were opened and the number of participants increased during the quarter.

Research and development of the pipeline of features for the PeriCoach® also continues to progress well.

During the quarter, Analytica lodged the 2015 R&D tax credit and expects a $1.9mn receipt in November.

In August, Dr Thomas Lönngren was appointed as a Non-Executive Director. Dr Lönngren brings significant regulatory and strategic advisory experience and network in the pharmaceutical and medical device industries.

“This quarter has been another period of substantial progress for Analytica as we continue to focus on our commericialisation goals for PeriCoach® of building the best-in-class product, market acceptance and developing partnership opportunities with multinational medical device companies,” said Analytica Chief Executive Officer, Geoff Daly.

“Our agreements with SalesForce4Hire and Current Technology will help us drive sales in the US – a key market for Analytica while sales in Australia and post approval clinical trial also continue to progress well. “

Download Announcement

APN Review October 2015

Asia continues to be the region of opportunity and growth

Home to 60% of the world’s population, Asia is experiencing rapid urbanisation and a fast growing middle class. Underpinned by unique demographics and GDP growth that is fast outpacing the Western world, Asia presents a compelling investment destination.

Real estate is a direct beneficiary of Asia’s growth which drives the demand for all forms of commercial property.

Asian Real Estate Investment Trusts (REITs) provide an ideal way to access this remarkable growth region for as little as $1000 initial investment, whilst offering the benefits of liquidity, portfolio diversification and professional management.

The APN Asian REIT Fund aims to deliver a competitive yield and long term capital growth by investing in a diversified portfolio of REITs across established real estate markets.

In this month’s Hot Topic we look at the growth currently being experienced in Japan’s key cities and provide you with an extensive report on The APN Asian REIT Fund by external research house, Australian Fund Monitors.

In this edition:

Martin Aircraft AGM Presentation October 2015

29th October 2015, ASX Announcement

Martin Aircraft Company Limited (MJP) is today holding its 2015 Annual General Meeting.

This has been a very special year for Martin Aircraft Company. The successful listing, following a round of pre-IPO capital raising, along with a commitment from our cornerstone investor KuangChi Science, has paved the way for the Company to move forward to providing a commercial Jetpack in the latter half of 2016.

Our focus has always been the development and commercialisation of the Martin Jetpack and associated products, and now with our financial backing we can really make progress on that journey.

To read the full announcement, please click here

Universal Biosensors Q3 2015 Results, Investor Presentation and CEO Audio Interview

29th October 2015, ASX Announcement

  • Total revenue up 187% on pcp to $6.0m
  • Quarterly Service Fees up 113% on pcp to $3.4m
  • Coagulation strip manufacturing revenue up 303% on pcp to $553k
  • Net R&D costs (including accrued R&D tax rebate) of $2.6m
  • Net loss of 163k (down from $1.9m on pcp)
  • Cash balance as at 30 September 2015 of $17.4m

To read the full announcement, please click here

To view the Investor Presentation, please click here

To listen to the CEO Interview, please click here

Prescient Fully Underwritten Up To Target Amount of $1.03 million

29th October 215, ASX Announcement

  • Funds to drive next stage development of promising lead drug asset PTX-200
  • SPP fully underwritten by Patersons Securities up to the target amount of $1.03 million and anticipated to fund key activities and milestones to Q3 2016
  • Multiple value creation points in next 12 months from PTX-200 trials in breast, ovarian cancers and Acute Myeloid Leukemia

Cancer drug development company Prescient Therapeutics Limited (ASX:PTX) (Company) is pleased to announce a Share Purchase Plan (SPP) fully underwritten up to the target amount of $1.03 million to underpin next stage development of its lead oncology assets.

The SPP provides the opportunity for existing shareholders to subscribe for up to $15,000 in new fully paid ordinary share (New Shares) without inuring brokerage or other transaction costs.

To read the full announcement, please click here

To read the Share Purchase Plan, please click here

Do You Know How Your Data is Being Used? – Booodl

It’s been a month of milestones at Booodl HQ. We took home two Australian App Design Awards for Best Fashion tech and Best New App, and we also doubled the number of stores in the Booodl retail network (taking the total to 15,000). This is great news in the lead-up to our official launch next month!

I also wanted to share my latest video on data privacy. Too often we click ‘Accept Terms & Conditions’ without really knowing what that means, and companies take advantage of it. Here I share Booodl’s perspective on the matter and what we’ll be doing to respect users’ privacy. You can read the original post in full on LinkedIn.

George Freney
Booodl Founder & CEO

SEERA Takes its Talent to the World

27th October 2015, Microsoft

It was an idea 13 years in gestation and now Microsoft Azure is helping to take talent management software company SEERA to the world.

Founded and led by dynamic CEO Bradley Birchall, SEERA came into existence four years ago but first started as an idea in his head more than a decade earlier when he was heavily involved in the establishment of Seek, now Australia’s leading employment website but then just an ambitious start-up trying to take on the job advertising sector which had long been firmly entrenched in newspapers.

“I was responsible for building Seek’s platform and operations,” Mr Birchall said. “I saw a flaw in the market that I approached the Seek board on, and said look: ‘It’s all good to provide a job site, but what we’re not addressing is the management of people and the management of organisations and how they deal with those people’.

“So that’s going back 13 years ago now, and at the time it would have been difficult to achieve due to the inherent technology constraints.  I always knew that one day I would realise the dream when the time was right.”

When that time came, Mr Birchall established SEERA and started building the first version in Java using Amazon Web Services, but after a year decided to switch to .net and the Microsoft Azure platform.

“It was a completely different approach to all existing HR solutions. You can profile people at the recruitment point which provides enormous savings for customers. With their profile and performance appraisal information you can then do things like gap analysis, project resourcing, and learning and development planning.  And you can automate all of those processes that were previously manual or cumbersome,” he said.

“What differentiates SEERA is that it uses competency frameworks as the foundation.”

It’s been a winning differentiator, with the company in recent times doubling in size every three to four months.

Helping to fuel that expansion was a move to Microsoft Azure.

“After we started using Microsoft Azure we found that the cost of developing and building out SEERA and the ongoing management costs using Azure were, on average, 30 to 40 per cent lower than AWS.  In addition, Azure allowed us to innovate on top of the platform to deliver value to our every growing customer base by adding new features and functionality on a regular cadence.”

SEERA has products for businesses at all stages of growth, from SMBs to enterprises, and the rapid growth is “because we’re providing features and functionality that just simply don’t exist in traditional HR solutions,” Mr Birchall said.

For the Australian Technical and Management College (ATMC), an educational institute with four campuses in Victoria, and ones in Sydney, Sri Lanka and Malaysia, SEERA has proved a godsend.

To read the full story, please click here

SingHaiyi Announcement On Changes In The Composition Of The Board And Board Committees


The Board of Directors (the “Board”) of SingHaiyi Group Ltd. (the “Company”) wishes to announce that the Nominating Committee has reviewed the appointment of a new independent Non-Executive Director and composition of Board Committees (Audit, Nominating and Remuneration Committees).

Based on the recommendation of the Nominating Committee, the Board approved the appointment of Mr See Yen Tarn as an Independent Non-Executive Director of the Company with effect from 1 October 2015.

Detailed template announcement on the appointment of Mr See as required under Rule 704(6) of the Listing Manual Section B: Rules of Catalist (the “Catalist Rules”) of the Singapore Exchange Securities Trading Limited (the “SGX-ST”) is being released separately via the SGXNET. Mr See is considered independent pursuant to Rule 704(7) of the Catalist Rules of the SGX-ST.

The Board would like to take this opportunity to extend its warm welcome to Mr See as the newest member of the Board.


Based on the recommendation of the Nominating Committee, the Board also approved that the appointment of Mr See as Chairman of the Nominating Committee and a member of Audit and Remuneration Committees with effect from 1 October 2015.

To download the full announcement, please by clicking on the link below. 

Proteomics Granted US Patent for Diagnostic Test

27th October 2015, ASX Announcement

  • Grant of US patent is a critical milestone in the development of the Diagnostic Test for Diabetic Kidney Disease in the world’s largest health care market
  • Patent provides protection as both a predictive and diagnostic test in the USA
  • Ability to accurately detect early onset of Diabetic Kidney Disease via a simple blood test has the potential to save health care systems globally $100s of millions annually

Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to announce it has been granted a US patent for its PromarkerD Diagnostic Test for the early diagnosis of diabetic kidney disease (DKD).

The patent provides protection for the use of PromarkerD as both a predictive (prognostic) and diagnostic test in the USA, and is valid until 20 September 2031. The patent entitled, “Method of assessing diabetic nephropathy using CD5 antigen-like “(patent number: US 9,146,243 B2).

To read the full announcement, please click here


Acquisition of Interest in Bateau Bay Square by Charter Hall

26th October 2015, ASX Announcement

Charter Hall Retail REIT (ASX:CQR) (CQR or the REIT) today announced that it has executed a conditional contract to acquire a 47.5% interest in Charter Hall Retail Partnership No. 2 (CHRP2 or the Partnership) which owns Bateau Bay Square on the Central Coast of New South Wales (NSW) CHRP2 is a management investment trust held between Charter Hall Group (ASX:CHC) (Charter Hall) and two institutional investors.

The REIT will acquire units in the Partnership from Charter Hall (42.5%) and one of the existing unitholders (5%) whoe will exit the Partnership following the successful completion of the contract. The transaction has been negotiated at arm’s length and is on the same terms as recent dealings in the Partnership units.

To read the full announcement, please click here

Atomo Diagnostics – CEO Interview

Atomo Diagnostics is a multi-award winning and rapidly growing medical device company that has developed and commercialised AtomoRapid™, the world’s first integrated device for blood based immunoassay rapid diagnostic testing (RDTs) in point of care settings.

Atomo launched its first test on the platform, AtomoRapid HIV, in 2014. Since launch, AtomoRapid tests have quickly established themselves as a “best in class” solution for professional use diagnostic screening.

With tests now commercialised for HIV and malaria and a rapid Ebola test ready for launch later this year, Atomo is disrupting global RDT markets where convenience, usability and safety have for many years been largely overlooked.

Please listen to John Kelly, CEO of Atomo Diagnostics below.

Rapid, Award Winning Diagnostic Tests to be Presented at MEDICA

23rd October 2015, News Medical

A Bloxham-based company focused on improving the usability, safety and accuracy of rapid diagnostic tests will present its fully integrated AtomoRapid™ product range at MEDICA 2015, the world’s largest medical trade fair.

Atomo Diagnostics will showcase its award-winning AtomoRapid HIV and AtomoRapid Malaria rapid diagnostic tests in Hall 1 Stand E06.

The company’s AtomoRapid platform replaces costly and time-consuming blood testing procedures by incorporating functionality into one easy-to-use device. The all-in-one platform removes the need for multiple test components and, by simplifying user steps, helps to address errors common with standard rapid diagnostic tests.

AtomoRapid HIV has established itself as the ‘best in class’ solution for professional use HIV screening and won both the In Vitro Diagnostic and ‘Best in Show’ categories at the Medical Design Excellence Awards 2014.

To read the full article, please click here.

YuuGames Bags Yet Another Major E-Sports Event in China

October 26TH 2015

Singapore-listed YuuZoo Corporation Limited (YuuZoo SGX: AFC.SI), one of the world’s fastest growing social e-commerce companies, is pleased to announce that it through its China joint venture YuuGames has secured the rights to co-organize the China Internet Gaming (CIG) 2015 e-sports competition with and the Ministry of Industry and Internet Technology (MIIT), the  department responsible for the administration of China’s industrial branches and information industry. 60 teams 15 provinces will compete for the top position and prize money of RMB 3.5 million (S$ 772,721).The event will kick off on November 2015 and culminate in a grand finale on 23rd January 2016, in Beijing.

The new agreement comes hot on the heels of YuuGames signing the agreement to host China’s top e-sports event ESCC (Electronic Sports Cup of China).

CIG will pay YuuGames to organize the event in four provinces and market the event across nine of the 15 provinces. In addition to the fee paid by CIG, YuuZoo will gain from the new deal by new users being added to the YuuGames platform, from promotional fees, advertising revenue and e-commerce sales.

Touted as one of the largest events in its category, CIG 2015 participants can choose from Real Time Strategy (RTS) games such as FIFA Online 3 and StarCraft II; Multi Online Battle Arena (MOBA) games such as League of Legends and DOTA 2; Massively Multiplayer Online Role-Playing Games (MMORPG) such as World of Warcraft; and card games. In addition to the professional teams, individual gamers can also participate in CIG 2015. This means CIG targets a different segment of gamers than ESCC which targets internet clubs and cafes.

With two of the largest e-sport events in China now hosted and managed by YuuGames, the company is fast emerging as a leading player in this fast-growing and lucrative business in China.

YuuGames, in conjunction with its hosting partners, plans an aggressive advertising blitz online, in print, and across broadcast media. This media blitz is supported by events to secure interest among the three million gamers expected at the event.

To read the full announcement, please click here

Proteomics Technical Presentation

26th October 2015, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to provide its latest technical presentation on it lead diagnostic test, PromarkerD.

The presentation was given as part of the 11th Australian Peptide Conference 2015, which is being held in Kingscliff, New South Wales from 25th-30th October 2015. The Company’s Managing Director, Dr Richard Lipscombe, was invited to give the presentation at the conference’s opening satellite meeting, titled ‘The “Omics” Revolution: Uncovering Proteome Complexity’ on Sunday 25th October.

To read the full announcement and view the presentation, please click here

SUDA to Present at Hong Kong Wholesale Investor Showcase

26th October 2015, ASX Announcement

SUDA Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, today announces that Mr Nick Woolf, Chief Business Officer, will present at the Wholesale Investor – Emerging Company Showcase in Hong Kong on Friday, 30 October 2015. This is part of SUDA’s initiative to broaden the Company’s investor base in Asia and to raise awareness of SUDA with high-net-worth private and sophisticated investors.

To read the full announcement, please click here

To read more on the event, please click here


Acquisition of Consumer Engagement Company nTouch Finalised

26th October 2015, ASX Announcement

  • YPB completes acquisition of proximity marketing & B2C engagement technology company nTouch
  • Excellent product and path to revenue synergies adding to YPB’s CONNECT strategy
  • nTouch to provide additional distribution channels within Australia, India & USA
  • $4.5 million all scrip acquisition

Anti-counterfeiting technology company YPB Group Limited (ASX:YPB) has signed a Share Sale and Purchase Agreement to acquire all the issued shares of proximity marketing technology company  nTouch Holdings Pty Ltd (“nTouch”). The closing date of the transaction is 30 October 2015.

Under the all scrip acquisition nTouch vendors will be issued $4.5 million in fully paid ordinary shares of YPB at $0.35 per share. Of the 12,857, 143 shares issued  7,728,937 will be subject to voluntary escrow for 12 months and 5,128,206 subject to volunrary escrow for 18 months.

To read the full announcement, please click here

Kube Systems Receives Another Quarter of a Million Dollar Order From its US Distributor

Kube Systems has just taken an order for a quarter of a million dollars from its US distributor.  This is the eighth order from Kube’s US distributor since Kube started in August 2014.

The Company took orders for $2.3m in its first year of operations.

The US distributor is American Hotel Registry (“AHR”), one of the largest suppliers of hospitality products in North America. Kube smartphone chargers are now represented in luxury hotels in the US across the world, including Starwood, Marriott and Four Seasons.

Kube Systems also has distributors in the UK, Europe, Middle East, India and Asia Pacific.

The Company is working on its second generation of smartphone chargers, designed to connect wirelessly to the internet, serve targeted local ads to customers as they charge their phones and become part of the Internet of Things.

Crowd Mobile Track Acquisition Update

23rd October 2015, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to confirm that all conditions precedent to the completion of the acquisition of 100% of the share capital in Track Holdings B.V. (Track Acquisition) under the share purchase agreement (SPA) have been met except for the completion of financial settlement which will occur at closing next week.

The Company is also pleased to advise that it has entered into variation to the existing SPA (Variation) to enable the immediate finalisation of the Track Acquisition. The key terms of the SPA are provided below.

To read the full announcement, please click here


Altech Chemicals Board Appointments Update

23rd October 2015, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise that it has appointed His Royal Highness Price Ya’cob Bin Tunku Tan Sri Abdullhah, as a non-executive director to Altech Chemicals Limited Board, and that the Price has nominated Mr Uwe Ahrens as his alternate.


Altech Chemicals Limited is aiming to become one of the world’s leading suppliers of a high-value product, 99.99% (4N) high purity alumina (HPA) (Al2O3). HPA is the major source material for scratch-resistant artificial sapphire glass, which is used in the next generation of smartphones as well as a growing range of high performance electronic applications such as LED’s, semi-conductors, and phosphor TV screens. The global HPA market is approximately 19,040tpa and is expected to double over the coming decade.

To read the full announcement, please click here.

Leaf Resources Placement Raises $1,000,000

23rd October 2015, ASX Announcement 

Leaf Resources have received commitments from sophisticated investors for a placement of shares through Lodge Partners. The placement, which will be conducted in two tranches, is for approximately 7.7 million shares at $0.13 raising approximately $1,000,000 before costs. The first tranche will settle on 28th October and the second tranche will settle on the 11th November 2015. The placement delivered the targeted amount.

The placement price of $0.13 represents a 13.33% discount to the closing price on Tuesday 20th October 2015, when the shares were suspended and a 15% discount to the 30 day VWAP to that same date.

To read the full announcement, please click here

IEV Signs Memorandum Of Understanding To Conduct Feasibility Study

The board of directors (“Directors”) of IEV Holdings Limited (“Company”, and together with its subsidiaries, “IEV” or the “Group”) wishes to announce that the Company had, through its wholly- owned subsidiary IEV Energy Sdn Bhd (“IEV Energy”), entered into a binding Memorandum of Understanding (“MOU”) with a consortium (“TL-Emrail Consortium”) comprising Timah Langat Holdings Berhad and Emrail Sdn Bhd (“Emrail”) today.

Under the terms of the MOU, IEV Energy and TL-Emrail Consortium (the “Parties”, and each a “Party”) will initiate and conduct a feasibility study (“FS”) to review the prospects of cooperating and successfully undertaking projects for the processing and transporting (“Throughput Services”) as well as the marketing of Liquefied Natural Gas (“LNG”) to industrial and vehicular sectors in Tamil Nadu, India. IEV Energy’s scope is limited to the market study and Throughput Services under the FS. TL- Emrail Consortium shall conduct FS for the LNG Complex and Floating Storage Regasification Unit, and prepare the necessary permits, licences, and approvals from the Government of Tamil Nadu.

Should the FS indicate that the LNG projects are feasible, the Parties will negotiate a throughput agreement, cooperation agreement, and/or other contractual arrangement(s) based on mutual consensus between the Parties.

The MOU is valid for a period of 12 (twelve) months and can be extended through a written notice between the Parties. The MOU will be valid as long as the cooperation between TL-Emrail Consortium and the Government of Tamil Nadu remains in place.

The MOU is not expected to have any material impact on the consolidated earnings per share and/or net tangible assets per share of the Group for the financial year ending 31 December 2015.

The Company will provide updates on material developments relating to this MOU as they occur. Each Party will bear its own costs of fulfilling its duties in the conduct of the FS.

To read the full announcement, please click here

BPS $100m Milestone Reaches in Real Estate Listings

22nd October 2015, ASX Announcement

BPS Technology Limited’s (ASX: BPS) Bartercard Division now has more than $100 million worth of Real Estate listing available throughout  its global network for its members to buy with an average of thirty five  (35) percent being payable in Bartercard Trade Dollars.

“There has been a lot of activity in the real estate sector in the last months and now more than ever members are looking to acquire investment property using their Trade Dollars”, said Trevor Dietz, CEO of BPS Technology Limited.

Bartercard has more than two hundred and fifty (250) properties listed on its various Real Estate Sites in Australia, New Zealand, South Africa, the UK and Thailand.

“With an average Trade Dollar component of thirty five (35) percent this means that members have the opportunity to spend more than $35 million which in turn creates even more opportunities for other members”, said Mr Dietz.

To read the full announcement, please click here

YPB Wins Two Awards at Security Document Summit

22nd October 2015, ASX Announcement


  • YPB recognised at Security document Summit (SDS) in Beijing
  • YPB wins “Excellent Application Award” for second year running
  • Also wins the prestigious “Innovation Award”
  • YPB is the only company to win two awards in 2015
  • 100 Companies exhibited at the SDS this year and 4,000 attended the exhibition

Anti-counterfeiting technology company YPB Group Limited (ASX: YPB) has received two awards at the 10th Annual Security Document Summit  (SDS) held in Beijing this week.

YPB received the award for “Excellent Application” for the second year running and added the 2015 “Innovation Award ” as part of the ‘Blue Shield Awards’ program announced in Beijing this past week. Annually SDS assess and grants five Industry Awards and YPB is the only company to win two of the prestigious awards this year.

To read the full announcement, please click here

Castle Point Investment Commentary – October

The latest Castle Point Investment Commentary is now available.

Please click here to view.

This investment commentary contains three articles:

Quarter in review
Equity market cross road

We start by discussing a rather volatile quarter.  In “Uber-Barbell” we comment on insights derived from a recent trip to Perth.  In “Equity market cross road” we discuss our views on potential paths for equity and other asset prices.

ISEC Propose Acquisition Of 100% Equity Interest in Southern Specialist Eye Centre


The Board of Directors (the “Board”) of ISEC Healthcare Ltd. (the “Company”, and together with its subsidiaries, collectively the “Group”) wishes to announce that its wholly owned subsidiary, ISEC Sdn. Bhd. (“ISECSB” or the “Purchaser”) had on 17 October 2015 entered into a sale and purchase agreement (“SPA”) with the following third parties, all of whom are independent of the Group :

(a) Yeo Kim Chuan (“ Dr Yeo”);
(b) Yang Phei Hua (“Mrs Yeo”);
(c) Wong Yew Meng (“Dr Wong”); and
(d) Liu Han Seng (“Dr Liu”),

(collectively, the “Vendors”) pursuant to which ISECSB had agreed to acquire the entire issued and paid-up share capital of Southern Specialist Eye Centre Sdn . Bhd. (Company No.: 1113344-M) (“SSEC”) from the Vendors (the “Proposed Acquisition”), further details of which are set out below in this announcement.

Following the completion of the Proposed Acquisition (“Completion”), SSEC will become a wholly owned subsidiary of ISECSB.


The Vendors are all residents of Malaysia and they are professional eye surgeons. Save for Mrs Yeo who is the spouse of Dr Yeo, the Vendors are not related to each other.

The shareholding breakdown in SSEC is as follows:

Name Number and Percentage Shareholdings
Dr Yeo 70,000 ordinary shares (70%)
Mrs Yeo 15,000 ordinary shares (15%)
Dr Wong 10,000 ordinary shares (10%)
Dr Liu 5,000 ordinary shares (5%)
Total 100,000 (100%)

SSEC is a private limited company incorporated in Malaysia in October 2014 and its registered office is at 48 Jalan Kota Laksamana, 2/15 Taman Kota Laksamana, Seksyen 2, Melaka, Malaysia 75200. SSEC’s sole business is that of operating specialist eye clinics. Dr Yeo, Dr Wong and Dr Liu are the resident consultant ophthalmologists of SSEC’s clinic. They were previously resident consultant ophthalmologist of K.C. Yeo Eye Specialist Clinic Sdn. Bhd. (“KCYESC”), which had an ophthalmology practice for 9 years since 2006 until 31 December 2014 when KCYESC transferred KCYESC’s ophthalmology business segment (the

Note: Unless otherwise stated, the exchange rate used in this announcement is based on S$1:RM3.02 as at the business day preceding the date of the SPA

“Segment”) to SSEC. In view of the aforementioned, the historical financial information of SSEC (prior to 1 January 2015) for the purpose of the Proposed Acquisition was prepared based on the Segment results in the unaudited adjusted and normalised accounts of KCYESC for the financial year ended 31 December 2014 (“FY2014”). The unaudited adjusted and normalised net asset value of the Segment was RM2,200,000 as at 31 December 2014. The entire issued and paid-up share capital of SSEC comprises 100,000 ordinary shares of RM1.00 each (the “Sale Shares”) with a total issued and paid-up share capital of RM100,000.

To read the full announcement, please click on the link below. 

AGM Presentation from Folkestone

22nd October 2015, ASX Announcement

FY15 Results – Highlights:

  • Net profit after tax of $7.0 million, up 122.6% on FY14
  • Earnings per share 1.1 cents, up 57.1% on FY14
  • Net asset value (NAV) per share of 17.5 cents, up 21.5% on FY14
  • Funds under management of $917 million, up 12.8% on FY14
  • Raised $42 million from a Placement and Entitlement offer
  • Launched the Folkestone Truganina Development Fund
  • Folkestone Social Infrastructure Trust merged with the Folkestone Education Trust (FET)
  • Acquired interest in three new development opportunities
  • Secured strong pre-sales across the active developments
  •  Completed development of Stage 1 at Millers Junction and entered into JV for stage 2

To view the full presentation, please click here

OncoSil Medical Appoints New CFO

22nd October 2015, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce the appointment of Mr Tom Milicevic as Chief Financial Officer and Company Secretary, effective from 22 October 2015.

Mr Milicevic is a vastly experienced commercial, financial and management accountant with more than 20 years’ experience in a career which includes a number of major Australian and international public companies.

He has specific financial expertise in medical device and biotech companies and his appointment represents a pivotal hire for the Company as it transitions from a development focus to the commercialisation  of its OncoSilTM localised radiation treatment for cancer.

To read the full announcement, please click here

BioDiem’s WHO PreQualification Certification Received

21st October 2015, BioDiem

BioDiem Ltd is pleased to announce that Serum Institute of India (SII), one of BioDiem’s LAIV technology commercial licencees, has received WHO prequalification (PQ) certification for their LAIV vaccine product, Nasovac-S™.

Nasovac-S is SII’s seasonal influenza vaccine which was launched into the Indian market in July 2014. The WHO PQ will open the market for Nasovac-S in the PAHO region and other UNICEF countries. SII will also be able to export to other markets however some regulatory review may be required in other export countries. This certification has been eagerly awaited and according to SII, relevant tenders should be open during 2016. One of SII’s strengths is in targeting tenders in developing countries.

To read the full announcement, please click here

BIG Outperforms Revenue Guidance and Investor Presentation

21st October 2015, ASX Announcement


  • BIG materially outperforms revenue guidance with $406,582 in cash receipts for the September quarter , up 75% on the prior quarter
  • Strong growth momentum of member base continues, reaching 10,000 members during the September quarter
  • Member base now sits above 11,000, reflecting a faster growth profile than relevant peers after the same length of time since inception
  • Sales expected to accelerate during the December quarter based on a robust sales pipeline and material uplift in recurring revenues

Big Un Limited (ASX:BIG, ‘BRTV’ or ‘the Company’ is pleased to announce it has exceeded its revenue projections for the September quarter. In Q3 2015 the Company generated $406,582 in cash receipts, well ahead of its $350,000 guidance and 75%increase on Q2 2015.

To read the full announcement, please click here

To view the Investor Presentation, please click here

Tellus Holdings Signs Equipment Supply and Finance MOU

20th October 2015, Tellus Holdings

  • Tellus signs MOU with CCTEG for mining equipment finance
  • Finance Package is valued at AUD$120 million
  • CCTEG is one of China’s largest state-owned enterprises, generating more than US$7B revenue and specialising in the manufacture and sale of specialised mining equipment

Tellus Holdings Ltd (“Tellus”) is pleased to announce it has signed a Memorandum of Understanding (MOU) with China Coal Technology and Engineering Group Corp (CCTEG) for the supply and finance of mining equipment to develop Tellus’ Chandler and Sandy Ridge Projects.

The package is valued at AUD$120 million and includes the supply and financing of mobile diesel equipment, conveyor systems, continuous miners, mobile bolters, auxiliary fans and salt handling plants.

An official signing ceremony in Beijing between the parties was attended by senior executive of both companies and accompanied by representatives from the Northern Territory Government.

“This is a great achievement for the Company and significantly de-risks our project equipment supply and funding requirements. CCTEG is a major supplier of high-quality specialised mining equipment to global operators, and also a leader in research and development of new mining technologies and processes,” Tellus Managing Director, Mr Duncan van der Merwe said.

CCTEG is one of China’s largest state-owned enterprises (SOEs), generating more than US$7B revenue from the manufacture and sale of specialised mining equipment and operating mines. CCTEG has been involved in the development and operation of more than 70% of China’s large underground coal mines.

“We look forward to working with CCTEG as the projects progress through bankable feasibility studies to finalise equipment requirements,” he said.

To read the full article, please click here

UBI Presentation at ASX CEO Sessions

21st October 2015, ASX Announcement

This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. This presentation is not financial advice and has been prepared without taking into account the objectives, financial situation or needs of a particular person.


Universal Biosensors (ASX:UBI) is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use. UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood.

The first product developed by UBI with LifeScan (a Johnson & Johnson company) is a blood glucose measurement device and is on the market and generating revenues for UBI; the second product, developed in collaboration with Siemens Healthcare, has also been launched. The global point-of-care diagnostics market is estimated to be worth nearly US$17 billion a year and growing. UBI is now extending its platform technology to new POC applications.

To view the presentation, please click here. 

Leaf Energy Present at Australian Microcap Investment Conference

21st October 2015, ASX Announcement

Leaf Resources Limited (ASX: LER) (“Leaf Resources”) is -leased to announce that its Managing Director, Ken Richards, will present at the 6th Annual Australian Microcap Investment Conference (“Microcap Conference”) on Wednesday, 21 October 2015 at 2.15pm.

The Microcap Conference is being held in Melbourne, over two days at the Sofitel Melbourne on Collins, in the ‘Arthur Street on Auditorium’.

To view the presentation, please click here

BPS Tech-Know Investor Presentation

20th October 2015, ASX Announcement

BPS Technology Limited is pleased to announce that it will be presenting the attached Investor Presentation at the Tech-Know Invest Roadshow alongside ASX technology companies like Freelancer and Migme. All BPS shareholders are invited to attend at the following venues:

20 October – Gold Coast, Marriot

22 October – Sydney, Grace Hotel

23 October – Melbourne, Grand Hyatt


BPS Technology Limited (ASX: BPS) provides technology and payment platforms centred on SME’s. It is a profitable business operates in eight countries, capitalising on a number of significant growth opportunities. BPS operates three highly complementary and scalable businesses – Bartercard, bucqi and TESS.

Bartercard operates the world’s largest trade exchange. It allows SME’s to conduct $600m of additional business without the use of cash. bucqi is a disruptive payment, loyalty & rewards platform that allows consumers to pay merchants via an app for goods and services without using a card or cash. TESS develops software for trade exchanges.  It is recognised and recommended as the preferred software by the global governing body of the industry.

To view the presentation, please click here.

Biodiem’s AGM Results, Chairman’s + CEO’s address 2015 AGM & AGM Presentation

AGM Presentation

The presentation includes: Chairman’s Overview, Review Of Operations, Highlights in FY2015 and Update, LAIV Influenza Vaccine Program, Antimicrobial (BDM-I) Program, Introducing Opal Technology, NIAID/USAMRIID Programs, Potential Product Line, Opal’s Development Plan, Corporate Activity, Outlook for FY2016.

View Presentation

2015 AGM Chairman’s Address

CEO’s address to the Annual General Meeting.

“I am pleased to report that we are now engaged in a series of activities which reveal that our outlook is most sound.”

View Chairman’s Address

2015 AGM CEO Address

CEO’s address to the Annual General Meeting.

“Our focus continued on the LAIV and BDM-I programs as the closest revenue-generating prospects for BioDiem… “

View CEO’s Address

Results of Meeting

BioDiem Limited results of Annual General Meeting 2015. We advise details of the resolutions and the proxies received in respect of each resolution as set out in the attached proxy summary. 1. Re-election of Prof. Larisa Georgievna Rudenko
2.  Amendment to Constitution

View AGM Results


YPB’s Investor Presentation

20th October 2015, ASX Announcement

Investment Highlights

  • Brand protection growing global issue
  • Suite of proprietary technology solutions
  • Consumer engagement tied to brand protection
  • High margin, growing and recurring revenue
  • Global clients global presence
  • Experienced and proven team

Huge Opportunity in Growing Global Market

  • $1.7 trillion current value of global counterfeit trade
  • $284 billion corporate and government spend combating counterfeiting
  • 70%  China’s share of counterfeits seized by US customs
  • 7% estimated share of global trade that is counterfeit
  • 300k people die each year from lethal counterfeit pharmaceuticals

To view the full presentation, please click here


iFAST Corp’s China Subsidiary Awarded A Funds Distributor Qualification In China

19th October 2015

iFAST Corporation Ltd. (“iFAST Corp” and together with its subsidiaries, the “Group”), via its Qianhai-registered subsidiary, iFAST Platform Services (Shenzhen) Qianhai Limited (“iFAST China”), has been awarded a Funds Distributor Qualification from the China Securities Regulatory  Commission (“CSRC”).

“We are pleased to have received the approval from the CSRC to be a Funds Distributor. The Qualification allows us to run an investment funds platform in China, a market we believe will continue to develop into an important global wealth management centre. We intend to work with different industry players in China to build an investment funds platform that can meet the wealth management needs of Chinese investors, in both onshore and offshore investment products,” says Mr Lim Chung Chun, Chairman and CEO, iFAST Corp.

Elaborating further, Mr Calvin Cheung, Regional Director (Greater China), iFAST China, believes that the close collaboration between China and Hong Kong will lead to a greater demand for a strong investment funds platform with cross-market capabilities: “The Mainland-Hong Kong Mutual Recognition of Funds scheme, for instance, opens up investment options for clients in China and Hong Kong. With our investment platform, we intend to reach out to clients by offering them a seamless experience that will enable them to diversify their investments.”

Mr Bernard Teo, General Manager of iFAST China, says that the company will continue to focus on its core strengths, while reaching out to Chinese clients: “Our experience in onshore and offshore operations, distribution of investment products from global fund houses and other financial institutions, robust research into investment products, and our in-house award-winning IT solutions, will offer an improved option to wealth management players and clients in China.”

About iFAST Corp

iFAST Corp (stock code: AIY) is an Internet-based investment products distribution platform, with assets under administration (AUA) of approximately S$5.71 billion as at 30 June 2015. Incorporated in the year 2000 in Singapore, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

iFAST Corp has two main business divisions, namely our Business-to-Consumer (B2C) website,, targeted at DIY investors; and our Business-to- Business (B2B) platform that caters to the specialised needs of financial advisory (FA) companies, banks and financial institutions. Over 5,000 wealth advisers from more than 150 FA companies, banks and financial institutions, use the iFAST B2B platform.

The Group’s mission statement is, “To help investors around the world invest globally and profitably”. The Group won the “Most Transparent Company Award 2015, New Issues Category” at the SIAS Investors’ Choice Awards 2015 held on 16th October 2015 in Singapore. The Group celebrates its 15th year anniversary in 2015.

For more information, please visit

To download the full announcement, please click on the link below. 

iFAST Receives Most Transparent Company Award 2015, New Issues Category at SIAS Investors’ Choice Awards 2015

19th October 2015

iFAST Corporation Ltd. (“iFAST Corp” or together with its subsidiares, the “Group”), an Internet-based investment products distribution platform, and the parent company of and iFAST Financial platforms, has won the “Most Transparent Company Award” under the New Issues category at the SIAS Investors’ Choice Awards held on 16th October 2015.

The SIAS Investors’ Choice Awards is an annual event held since 2000 to recognise listed companies who have improved and excelled in corporate governance and transparency practices. Singapore Management University, Sim Kee Boon Institute has been appointed by SIAS to conduct research findings pertaining to the selection process, which is based on the Singapore Corporate Governance Index (SCGI), a balanced weighted index which covers five aspects in accordance with OECD principles (Source: SIAS).

As for the Most Transparent Company Award supported by the Singapore Exchange, the “Disclosure and Transparency” aspects of shortlisted companies are assessed based on the information disclosed and made available publicly, as well as the company’s performance. Subsequently, industry partners, members from the media and SIAS review and nominate the shortlisted companies, and thereafter, the selection committee members will decide the winners based on quantitative and qualitative inputs (Source: SIAS).

Mr Lim Chung Chun, Chairman and CEO of iFAST Corp, said, “We are very honoured to be awarded the Most Transparent Company Award for newly listed companies. Transparency has always been a core focus in our business and that has guided us from the time we started business 15 years ago with the launch of Back then, information on funds was seen to be limited and we wanted to change the way the funds distribution business worked by giving transparent information on funds, including the fees and research. This focus on giving transparent information to investors is again what drove us to launch recently, by providing transparent information on bonds, as we believe bonds are a simple investment product that has so far been mainly offered to institutional clients only. We have wanted to change this by empowering investors with our transparent information on bonds, including our research, tools and pricing.”

Mr Lim added, “Staying true to our mission statement ‘To help investors around the world invest globally and profitably’, the company remains committed in embracing a transparent business model that can benefit clients in the long run and we want to thank the investment community or their trust in us.”

About iFAST Corp

iFAST Corp (stock code: AIY) is an Internet-based investment products distribution platform, with assets under administration (AUA) of approximately S$5.71 billion as at 30 June 2015. Incorporated in the year 2000 in Singapore, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to
banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

iFAST Corp has two main business divisions, namely our Business-to-Consumer (B2C) website,, targeted at DIY investors; and our Business-to- Business (B2B) platform that caters to the specialised needs of financial advisory (FA) companies, financial institutions and banks.

iFAST Corp has two main business divisions, namely our Business-to-Consumer (B2C) website,, targeted at DIY investors; and our Business-to- Business (B2B) platform that caters to the specialised needs of financial advisory (FA) companies, banks and financial institutions. Over 5,000 wealth advisers from more than 150 FA companies, banks and financial institutions, use the iFAST B2B platform.

The Group’s mission statement is, “To help investors around the world invest globally and profitably”. The Group celebrates its 15th year anniversary in 2015.

For more information, please visit

To download the full announcement, please click on the link below. 

Folkestone States ‘Market Forces Continue to Re-Shape the Real Estate Funds Management Industry’

We are heading into uncharted waters – historical low interest rates, strong capital flows into real estate, below trend economic growth, at the same time as we encounter significant change and disruption in the marketplace.

Mr Adrian Harrington, Head of Funds Management at Folkestone, speaking at PIR’s Annual Property Conference last week said “that market forces continue to re-shape the landscape of the real estate funds management industry. We are witnessing some of the most significant social, demographic and technological changes, and these are gaining momentum as they interact with one another. Together, they are having a significant impact on the way we live, work and play. The real estate industry provides both the accommodation to allow us to live (housing), work (office, retail, industrial, etc.) and play (hotels, entertainment facilities) and also an investment opportunity. Therefore, real estate fund managers more than just about any other industry sector, need to closely examine both their real estate and business strategies, to position themselves to take advantage of these opportunities going forward.”

Mr Harrington said that whilst real estate fund managers need to adapt to these changes, the hallmarks of top performing managers is founded on five key principles:

1.      a disciplined and focused strategy for each fund – clear and concise strategy/objectives with implementation that avoids style drift;

2.      strong alignment with investors – co-investment, fee structures and exit strategies that put investors first;

3.      delivering active performance – generating alpha through active management rather than relying on market beta;

4.      adopting appropriate capital structures – optimising the capital structure but at the same time avoiding over-leverage to generate short-term returns; and

5.      a focus on risk management – implementing frameworks that identify, price and manage risk appropriately through the entire process from acquisition to management to disposition.

Mr Harrington said “Given where we are in the economic cycle and the changes being brought by these mega trends, it is not surprising that investors and their advisers are becoming more demanding of their managers when it comes to reporting, risk management processes, governance and succession planning. This is a good thing.”

Commenting on the state of the real estate market, Mr Harrington said “there is a significant amount of money, much of this from offshore investors, looking to acquire Australian real estate. Despite nearing historical lows, on a global basis, yields on Australian non-residential real estate still look attractive and with the low dollar, this is attracting both institutional and private money from the US, Europe and Asia. Many of these investors have a lower cost of capital than Australian investors, and as a result, domestic managers are finding it harder to compete.

“Real estate fund managers, now more than ever, need to focus on the underwriting, structuring, financing and executing of transactions, whether it be acquisitions or dispositions. As managers, our job is to maximise the risk-adjusted returns of our investors, and sometimes that means saying – no this isn’t the right time to invest or this isn’t the right strategy for this point in the cycle or maybe we should take some money off the table. There will be still opportunities to deploy capital especially in areas benefiting from some of these mega trends like real estate related social infrastructure (child-care, medical, aged care) although managers need to remain disciplined.”

 For a copy of the presentation please click here.

Mobotech Releases its Latest IM Overview

Mobotech is pleased to release its latest IM overview for their capital raise. The opportunity brings a totally new clean-green-tech based product to ill-equipped global logistics.

Mobotech has a validated market, a patented award winning product and engaged customers.

To view the latest IM please download the document below.

Mobotech designs and builds mobile robots (Mobots) for the fast moving consumer goods (FMCG) industry. Our vision is to arm Supply Chains with smart-connected Mobots that autonomously shuttle customer-ready loads all the way from point of manufacture to point of sale.

Everyday thousands of additional trucks are rolled to move bread around the country because each truck cannot be loaded to capacity. Bakery and Dairy workers are operating with unsafe practices to keep up with productivity requirements. Worker safety violations, injuries and turnover are common given the physical demand and repetitive nature of loading trucks. In the US this is a $100M+ p.a. problem.

Mobots are zero-turning, electric, load transfer vehicles that fill trucks to capacity, eliminate hassles with manual labour and facilitate as mobile technology platforms.


Quickboat Holdings Pty Ltd CEO Interview

Quickboats has developed, patented and commercialised a unique 3.7m advanced composite folding boat set to disrupt the global water adventure market. Over 300 Quickboats were sold worldwide at a retail price of A$4990, during limited release.

The Quickboat breaks the barriers preventing millions of people worldwide from owning a boat – storage, transport and cost. The Quickboat is pitched as the next addition to any active family’s garage. Current backlog of 5000 expressions of interest awaiting the new supply of boats. Quickboats is seeking $2m to fund expansion and its global online scalable sales and marketing strategy.

Please listen to Mr Deryck  Graham, Managing Director, for more information. 


Proteomics International Wins WA Industry and Export Award

19th October 2015, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce it has been awarded the Health and Biotechnology Export Award at The Western Australian 2015 Industry and Export Awards.

The award was presented at a Gala Dinner on the 16th October, hosted by WA Premier Colin Barnett, and it recognised outstanding international success in medical, healthcare and biotechnology fields for its products, technology, equipment, or services.

PILL was delighted to receive the Healthcare and Biotechnology Award. It provides significant validation for the Company’s world-leading expertise and capabilities in area of proteomics, the industrial scale study of the structure and function of proteins.

To read the full announcement, please click here

Proteomics International Laboratories Appoints New Director

16th October 2015, ASX Announcement

Life science company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the appointment of Mr James Moses to the Company’s board as an executive director, effective form today.

Mr Moses has extensive experience in investment markets and the media developed in a career spanning 25 years, including a wealth of expertise in advising emerging small-cap public companies.

He will work closely with the Company’s leadership team to develop and implement appropriate strategies to maximise PILL’s awareness and penetration in investment markets and with external stakeholders.

To read the full announcement, please click here

Avenir Capital September 2015 Quarterly Investor Letter

The Avenir Value Fund has returned +1.8% net of fees year-to-date.

Adrian Warner was recently featured in Commonwealth Bank: MyWealth and discussed two investment ideas in the Australian market: Read More

Please click the link to view the Avenir Capital September 2015 Quarterly Letter.

If you would like to discuss how Avenir Capital can complement your investment portfolio, please do not hesitate to contact us.

YPB Solution for First World Economy ePassports

19th October 2015, ASX Announcement


  • YPB’s VariSec technology to be applied to 15 million ePassports
  • Total contract value in 2015 approximately $600,000
  • Potential for YPB technology to gain acceptance across many other economies

Anti-counterfeiting technology company YPB Group Limited (ASX: YPB), together with its production partner, has been contracted by a major first wold economy to supply sufficient of its propriety VariSec technology to apply  to the 15 million ePassports it will be supplying during calendar 2016. With delivery to occur in December 2015.

The use of this technology will increase the number of ePassports containing YPB technology to more than 125 million globally.

To read the full announcement, please click here.

MyWave Launches Intelligent Assistant, Frank, in the US

16th October 2015, By Joanne Frearson, Business Insider

MyWave has launched an Intelligent Assistant, called Frank, in the US where the consumer has control of their personal data.

Geraldine McBride founder and CEO of MyWave launched Frank at her keynote address at the Intelligent Assistant Conference in New York, which makes customer’s lives easier by transforming their interactions into a ‘Customer-Managed Relationships (CMR).’

It does this by allowing the consumer to control and update their own data based on their preferences and buying intentions, and share their preferences and needs in real-time, enabling a business to tailor products and services in a far more targeted and relevant way.

Founded by McBride in 2013, MyWave is the first technology company with an Intelligent Assistant to commercialise CMR.

According to McBride the old Customer Relationship Management (CRM) is outdated and will ultimately be rejected by consumers who no longer consider themselves, to be ‘passive participants’ at the end of the sales cycle.

To read the full article, please click here

Listen to ‘SUDA Allowed US Patent for Sildenafil Products’ Webcast

16th October 2015, ASX Announcement

SUDA Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, provides the opportunity to listen to an audio broadcast with Mr Stephen Carter, SUDA’s Managing Director & CEO, in a presentation  titled:

“SUDA allowed US Patent for sildenafil products”

To listen, please click here.

To read the fill announcement, please click here.

TFS to commence trial of treatment for cancer side effect

16th October 2015, ASX Announcement


  • TFS’s US-based subsidiary, Santalis Pharmaceuticals, has been granted FDA allowance to commence trials of an oral rinse to treat Oral Mucositis
  • Oral Mucositis is an acute inflammation and ulceration of the surface of the mouth and throat common among cancer patients receiving chemotherapy and radiation therapy
  • Santalis has also received allowance to expand a Phase 2 study in the treatment of Molluscum Contagiosum Virus, a contagious and highly prevalent skin virus, particularly in children

TFS Corporation Limited (“TFS”, ASX: TFC), the world’s largest owner and manager of commercial Indian sandalwood plantations, is pleased to announce that it has received US regulatory allowance to commence a study in the prevention of and treatment of cancer-associated mouth condition using the Company’s pharmaceutical grade East Indian Sandalwood oil (“EISO”).

To read the full announcement, please click here

Altech Company Presentation Video by MD Iggy Tan

15th October 2015, ASX Announcement


  • Importance of artificial sapphire in the LED and electronics industries
  • Demand for High Purity Alumnia
  • Altech’s processing advantages
  • Results of the Company’s Bankable Feasibility Study
  • Update on project funding and HPA off-take

Altech Chemicals Limited (Altech/the Company) (ASX:ATC) is pleased to make available to shareholders a Company presentation by managing director, Mr Iggy Tan at the Melbourne Resource Round Up on 1 October 2015.

To watch the video, please click here

To read the full announcement, please click here

Folkestone Enters Joint Venture to Acquire Strategic Site in Sydney’s North-West

15th October 2015, ASX Announcement

Folkestone  Limited (ASX: FLK) is pleased to announce that it has entered into a 50/50 joint venture with the Lyon Group Australia, a leading Sydney property developer, (“Folkestone Lyon JV”) to acquire development rights over 59.7 hectares currently owned or under option by an entity associated with the Lyon Group in South Dural (“Folkestone Lyon Land”).

The Folkestone Lyon Land forms a key component of the 240 hectare (590 acres) area known as South Dural. South Dural is strategically located between the rapidly growing suburbs of Glenhaven and Kellyville and the established areas of Castle Hill and Cherrybrook in Sydney’s north-west. It is approximately 2.0 kilometres from the new Castle Hill railway station and 2.5 kilometres from the Cherrybrook railway station, both of which are key stations on the Sydney Metro Northwest rail line currently under construction.

The Folkestone Lyon JV is seeking the rezoning of South Dural, which includes the Folkestone Lyon Land to facilitate residential and mixed use development in an integrated manner under the NSW Government’s Gateway Determination dated 4 March 2014. The Folkestone Lyon JV is working collaboratively with the South Dural Residents and Ratepayers Group as the Preferred Developer Proponent, Hornsby Shire Council and the NSW State Government to have South Dural rezoned.

Under the terms of the arrangement between Folkestone and the Lyon Group, the majority of the optioned land is not anticipated to settle until FY18. At the commencement of the JV, Folkestone has committed $6.0 million in equity and loans to the JV and entities associated with the Lyon Group and will be required to commit further funds in FY17 and FY18 to fund its share of development expenditure and settlements.

Folkestone’s Managing Director, Mr Greg Paramor said “the State Government’s draft North Subregional Strategy sets out a target of 11,000 new dwellings and 9,000 new jobs in the Hornsby Shire by 2031. The rezoning of the South Dural land to residential will make an important contribution to meeting the dwelling target of the Hornsby Shire Council. It will also assist the NSW Government achieve its objective of accelerating the delivery of new housing in Sydney to meet the needs of a growing population, to satisfy a growing demand for different types of housing and improve housing affordability.”

To read the full announcement, please click here

Leading Chinese Industrial Association Selects YPB

15th October 2015, ASX announcement

  • YPB to provide suite of solutions to leading industry association for three years
  • Expected revenue of more than $1.5m for life of the contract
  • Potential for YPB across more than 100 similar associations in China

Anti-counterfeiting technology company YPB Group Limited  (ASX: YPB) has been selected by a leading Chinese industrial association as its brand protection solution provider for the next three years.

YPB will provide its comprehensive suite of solutions to PROTECT products, DETECT counterfeits and CONNECT Chinese consumers with the brand owners under the national association. It is anticipated that revenue over the life of the contract will exceed $1.5m.

China has more than 100 similar industry associations across all sectors providing YPB an outstanding opportunity to market its integrated approach to brand protection and authentication.

To read the full announcement, please click here

Latest Letter to SUDA Shareholders

15th October 2015, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today published a shareholder newletter, which will be mailed to shareholders who have requested hard copies.

Mr Stephen Carter, Chief Executive Officer of SUDA said: “The newsletter is a valuable forum for us to put recent news in context; to highlight upcoming events; and to set out in more detail some of the exciting assets and activities at SUDA”.

Stories include:

  • Upcoming Events
  • Westcoast’s core business continues to outperform
  • Successful ArTiMistTM publication strategy
  • New ArTiMistTM patent granted in South africa
  • ZolpiMistTM market research
  • Plus more stories

To view the latest newsletter, please click here

UBI Shareholders Communication 15 October 2015

Dear Shareholder

Universal Biosensors, Inc. has released the following information on Thursday 15 October 2015 regarding;

- Appendix 4C – Quarterly.  To access the link, please click here.

- Development Update UBI PT-INR Testing System.  To access the link, please click here.

Alternatively, all the releases are also available on our web page

Yours sincerely

Universal Biosensors, Inc.

Development Update UBI PT-INR Testing System

15th October 2015, ASX Announcement

Universal Biosensors, Inc. (ASX: UBI) today provided the following development update with respect to its own PT-INR testing system to be used in decentralised settings (e.g. doctor’s offices and the home).

The Company is currently undertaking a program of product reliability and performance testing to verify that the system is ready for clinical trials and usability studies.

At the same time it is finalising arrangements with clinical sites in preparation for the start of regulatory clinical trials.

As soon as sufficient clinical data has been collected to demonstrate performance across an appropriate patient population, the Company will be in a position to see CE Mark self-certification and approve the product for initial European release. It is anticipated that this will now occur in the first half of 2016, noting that the majority of the costs of associated product development are expected to be incurred before the end of 2015.

To read the full announcement, please click here

8i Raises NZD$20m with Hollywood Help

15th October 2015, By Holly Ryan, NZ Herald

Movie star Ashton Kutcher and Samsung are among the group of global investors backing a Wellington-founded virtual reality company 8i to the tune of $20 million.

The company, co-founded by Linc Gasking in May last year, has developed a platform that enables users to create, experience and share lifelike 3D video using a virtual reality headset.

It would be using the funding, from venture firms, including Kutcher’s Sound Ventures, RRE Ventures, Founders Fund Science, Horizons Ventures, Samsung Ventures and Dolby Family Ventures, to hire staff and fund growth.

“8i records people in a new, more advanced approach than cinematic 3D, allowing viewers to move around freely and experience an authentic feeling of emotional connection with the person they’re watching,” Gasking said.

To read the full article, please click here

8i Raises USD$13.5M To Chase The Human Side Of Virtual Reality

15th October 2015, By Drew Olanoff, TechCrunch

There I stood, about a foot away from a mother and her newborn baby. The mother was talking to her daughter in a video captured in virtual reality for the child to see one day when she’s older. It was realistic. Almost scarily so. I was able to walk around a “room” and watch the mother speaking from every angle, including behind her.

I’ve never seen that much human detail with a VR getup on my face.

The really trippy part? The company shot followup footage a few weeks later and seeing the child “grow” with my own eyes was nuts.

That is 8i’s speciality and the New Zealand / Los Angeles / San Francisco based firm has announced a $13.5 million Series A round with participation from an interesting mix of investors to make VR more human: RRE Ventures, Founders Fund Science, Horizons Ventures, Samsung Ventures, Dolby Family Ventures, Bertelsmann Digital Media Investments, Sound Ventures, Signia Venture Partners, Inevitable Ventures, Freelands and Advancit Capital, Kevin Wall, Jeremy Stoppelman, John and Andrew Hendricks, End Cue and Kortschak Investments, Rothenberg Ventures and Boost VC.

8i is building a platform so that content creators can make their own 3D renderings and VR experiences available in anything from a dating app to a feature film. The 360-degree stuff is a nut that 8i cracked and it’s no wonder that there is a lot of interest around them. I mean, Samsung Ventures’ and Dolby’s involvement speaks volumes. The company is also opening a studio in Los Angeles that they plan on letting content creators use for free. The more creativity that flows around the technology, the better it can get.

“We’re focusing on a really hard problem, to bring humans into augmented realities,” 8i CEO Linc Gasking told me.

To focus on the humanity aspect was important for Gasking and his team of 27 (and growing), who come from companies like Pixar, DreamWorks, YouTube, Industrial Light & Magic, PayPal, Microsoft Research, Sony Computer Entertainment, Digital Domain, NVIDIA, Weta Digital and Valve.

To read the full article, please click here.

$12m R&D Tax Refund for Carnegie Wave

14th October 2015, ASX Announcement

Wave energy developer Carnegie Wave Energy Limited (ASX: CWE) is pleased to announce the receipt of a Research and Development Tax Incentive cash rebate from the Australian Tax Office of $12 million.

The R&D Tax Incentive provide a tax rebate to support Australian companies to undertake Australian research and development. During the year ended 30 June 2015 and prior years Carnegie incurred eligible R&D expenditure from which the tax rebate was calculated.

To read the full announcement, please click here

Scoping Study for Renewable Chemical Project by Leaf Resources

14th October 2015, ASX Announcement

Scoping Study Highlights:

  • Net present value after tax of US$720m
  • After tax Internal Rates of return of over 81%
  • Study shows attractive returns achievable for renewable chemicals made from biomass

Leaf Resources recently commissioned ResourceInvest Pty Ltd to undertake a scoping study for a renewable chemical project based on experienced inputs and revenue from a “typical” renewable chemical.

The study showed that the returns for a project taking biomass through to a “typical” chemical are very attractive delivering a NPV for the project of over US$720m after tax.

To read the full announcement, please click here



TFS Corporation Annual Report to Shareholders

12th October 2015, ASX Announcement

The Company reported a net profit after tax of $113.0 million and cash EBITDA of $57.5 million, both higher than the prior year and ahead of guidance. This was supported by increases in sandalwood product sales and lease and management fees, as well as ongoing strong demand for new plantations. Importantly, TFS recorded threefold growth in cash from operting activities, at $24.6 million. The Board elected to maintain a final dividend of 3 cents per share.

Pleasingly, TFS also delivered on its strategic priorities for the year to advance the Company’s ‘soil to oil’ strategy. Of those priorities, I would like to reflect on three key opportunities I outlined when addressing shareholders for the first time as Chairman of TFS at the 2014 Annual General Meeting.

To view the full report, please click here

Second Chinese Bank Adopts YPB’s Technology

12th October 2015, ASX Announcement

  • YPB signs second major Chinese bank printing deal
  • Major Chinese bank with 1,300 branches nationally – Fortune Global 500 company
  • In conjunction with its Chinese security printing partner YPB will provide its invisible tracer and scanners for use on bank documents
  • New customer attracted to YPB’s high security low cost per application solution

Anti-counterfeiting technology company YPB Group Limited (ASX:YPB) has been selected to provide its tracer and scanners to one of China’s largest national banks.

The second major banking customer to implement YPB’s anti-counterfeiting solution. The bank is one of the largest National Banks in China  with more than 1,300 branches and total assets of RMB 4.6 trillion. It is recognised as one of the Fortune Global 500 enterprises and has been named in Banker magazine as one of the world’s top 50 banks.

To read the full announcement, please click here

OncoSil Medical CE Mark Update

12th October 2015, ASX Announcement

OnoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to provide the following update on its Conformité Européenne (CE) Mark application for the Company’s OncoSilTM localised radiation treatment for cancer.

As previously advised (ASX announcement, 9 September 2015), OncoSil Medical was granted a Fast Track review by the European regulator to assess its CE Mark application for OcoSilTM in pancreatic and primary liver cancer (HCC).

OncoSil Medical now advises that the Fast Track Face-To-Face review phase has been completed, and it now awaits the final outcome of the review as the Notified Body continues to its assessment over the coming weeks. The Compnay was pleased with the review meeting and anticipates that the Notified Body will make a decision in respect of the CE Mark for OncoSilTM in November.

To read the full announcement, please click here.

Latest Prototype Jetpack Secures CAA Approval

12th October 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft) (ASX: MJP) is pleased to announce that the latest model of its Prototype 12 (P12) aircraft (P12.3) has achieved New Zealand CAA approval for manned flight.

The P12 family of Martin Jetpacks with their distinctive mid-mounted fan ducts are prototype aircraft being used for commercial development and flight testing. They are the forerunner to the Martin Jetpack Next Generation (NG) aircraft which the company plans to deliver to First Responder customers from the latter half of 2016.

P12.3 registered as ZK-JMK passed its Sports Aircraft Corporation (SAC) annual airworthiness inspection and received a New Zealand Civil Aviation Authority (CAA) Manned Flight Permit. This third aircraft in the P12 series differs from previous as it has been built in a production-environment, using rigorous build-configuration controls and processes.

To read the full announcement, please click here

Interview with Managing Director Iggy Tan from Altech Chemicals

10th October 2015, ASX Announcement 


  • Importance of artificial sapphire in the LED and electronics industries
  • Results of the Company’s Bankable Feasibility Study
  • Update on project funding and HPA off-take
  • The next 12 months

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises that an interview by Finance Network News was recently conducted with managing director, Mr Iggy Tan, and is now available for viewing.

To view the full announcement, please click here

To watch the interview, please click here

MedAdvisor Limited Receives Commitments to Raise $5m in Oversubscribed Public Offer


  • MedAdvisor to list on the ASX via Exalt Resources (ASX:ERD)
  • Offer attracts strong support from domestic institutional investors and pharmacy industry participants
  • MedAdvisor has established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA
  • One quarter of Australian pharmacies subscribe to the MedAdvisor cloud-based pharmacy platform

MedAdvisor International Pty Ltd (MedAdvisor), an Australian medical technology business focused on designing and commercialising world class software platforms for medication management, has extended its oversubscribed Public Offer under Prospectus dated 7 September 2015 via Exalt Resources (ASX:ERD). The Offers under the Prospectus will close on Friday, 16 October 2015 to facilitate clearance of funds.

Exalt Resources offered up to 166 million shares at an issue price of $0.03/share under the Public Offer, to raise up to $5 million (Offer). The Company has received applications and firm commitments for well in excess of the maximum subscription for shares under the Offer and will have an indicative market capitalisation of $20 million. The Public Offer is managed by Corporate Advisor, Peloton Capital.

MedAdvisor has developed a world-class software platform that assists individuals in correctly using medication via a ‘virtual pharmacist’, improving their health outcomes through improved medication adherence. The software uses a cloud computing approach, in conjunction with optimised user experience, on mobile and web devices.

MedAdvisor’s platform and free apps have achieved early success with pharmacies and consumers. The app is free for consumers and is actively being used by 93,000+ Australians; one quarter of Australian pharmacies are paid subscribers, and it has been the most downloaded medication-related app in Australian Apple and Android stores since 2013.

Mr Peter Bennetto, Chairman of Exalt Resources, said: “The MedAdvisor Offer has attracted strong support from institutional investors, pharmacies and pharmacy groups. We are very pleased to announce the Offer is substantially oversubscribed and we are no longer accepting applications. The Company’s timetable for commencing trading is not affected by today’s extension and we look forward to formally closing the Offer in the next week.”

Mr Robert Read, Chief Executive Officer of MedAdvisor said: “We are delighted by the overwhelming response to the Offer and high demand particularly from priority investors including pharmacy companies and groups.

“We have already commenced the development of a number of exciting new initiatives work, as detailed in our Prospectus, and post-listing, we will continue work on boosting our marketing activity to attract a high volume of new customers.”

About MedAdvisor

MedAdvisor is an Australian software systems developer focused on addressing gaps in personal medication adherence. MedAdvisor’s free app connects to pharmacy dispensing systems to automatically retrieve medication records and drive an intelligent training, information and reminder system to ensure correct and reliable medication use. It was the most downloaded pharmacy or medication-related app in Apple and Android stores in Australia in 2014 and 2015, and is being used by more than 88,000 Australians. A quarter of all Australian pharmacies subscribe to the MedAdvisor software platform.

MedAdvisor has established sales and marketing partnerships with private health insurer, BUPA, and has training and service contracts with top tier global pharmaceutical companies, including GSK, AstraZeneca, UCB and Apotex.

To download the full announcement, please click on the link below. 

Australian Cities – Globally Competitive But Can They Stay There?

The recent appointment of Jamie Briggs as the Minister for Cities and the Built Environment sends a strong message that our Federal leaders finally recognise that our cities are an essential ingredient in driving Australia’s economic and social prosperity.

Our cities are home to our most valuable capital – human capital. Almost 80% of the Australia’s population live in our major cities and over 60% live in Australia’s five largest cities alone – Sydney, Melbourne, Brisbane, Perth and Adelaide. Australia’s strong population growth is projected to continue into the future, with the ABS’s medium projection estimating that Australia will grow to just over 30 million people by 2031. The majority of this growth is expected to occur in and around Australia’s capital cities.

Australia’s cities generate the majority of the country’s GDP, and also house much of the nation’s key economic infrastructure, such as ports and airports and provide the majority of Australia’s jobs. Australia’s economic structure is changing rapidly as we move away from agriculture, manufacturing, and resources to a more service orientated economy that is heavily biased to cities.

Australian cities are among the fastest-growing in the developed world and on most major economic and livability rankings fight well above their weight. According to the latest Forbes Most Influential Cities Rankings[1], Sydney tied with Beijing as the eighth most influential city in the world, the 2015 Global Financial Centre Index[2] ranked Sydney 15th and Melbourne 27th while the Economist Intelligence Unit’s 2015 Global Livability Ranking[3] ranked Melbourne 1st, Adelaide 5th, Sydney 7th and Perth 8th.

To read the full article, please click here

Bulletproof Completes Acquisition of Infoplex

8th October 2015, ASX Announcement

Acquisition Complete- SPP Update

  • Acquisition of Blue Chip private cloud company Infoplex Pty Ltd completed
  • Share Purchase Plan closes on 30 October 2015

Bulletproof Group Limited (ASX:BPF) is pleased to announce that the acquisition of  Infoplex Pty Ltd as announced on 16 September 2015, has today been completed with the initial payment of $3.3m to the vendor. A further $250k is due under the Share Purchase Agreement on 31 January 2016. We are also very pleased that a dozen Infoplex Pty Ltd have today commenced as Bulletproof employees, further bolstering the Company’s enterprise and private cloud skillset. The Company has now begun executing on its integration and synergy implementation plans.

To view the full announcement, please click here

Booktrack Announces New Content Deals

7th October 2015, DBW

Booktrack (, the first company to enrich the eBook experience by adding movie-style soundtracks and ambient sound while you read, today announced content partnerships with Sourcebooks, RosettaBooks, the Nelson Literary Agency, Orca Book Publishers and Mighty Media Press. These deals were inked just in time for the Frankfurt Book Fair, where Booktrack’s CEO and Co-Founder Paul Cameron will be speaking on the panel for the “Hug the Alien” session on October 16 at Frankfurt’s Business Club and Vice President of Publishing Cameron Drew will be participating on the “International Self-Publishing and Author Program” session on October 17.

“We’re thrilled to announce Booktrack’s strong momentum in securing relationships with key publishers,” said Paul Cameron, CEO and Co- founder, Booktrack. “We believe the future of reading will involve people reading on Kindle and mobile devices with a contextual and synchronized soundtrack played in harmony with the story delivered via wireless headphones or Echo style AI sound speaker systems, in the same way film was forever changed with the addition of sound. Previously, the reading experience was the only mainstream entertainment medium that lacked synchronized sound, that all changed when we invented the new category of Soundtracks for Books. Book publishers appreciate that Booktrack is the only reading enhancement delivered while you read. We don’t interrupt the reading process, but rather enhance the experience while keeping users engaged. Booktrack is uniquely positioned to help publishers and authors re-invigorate sales of backlist titles by re-issuing them in a new compelling way with a soundtrack.”

To read the full article, please click here.

Global Drug Giant Merck is Investing in Australian Biopharmaceutical Bionomics

8th October 2015, By Chris Pash, Business Insider

Global drug giant Merck & Co has made a strategic investment in an Australia biopharmaceutical company Bionomics, which works on the discovery and development of treatment for cancer and diseases of the central nervous system.

Merck, one of the largest pharmaceutical companies in the world, is buying 21,659,230 million shares at $0.5938, a 29% premium to Bionomics’ closing price on Wednesday, a total investment of about $12.8 million.

The news sent Bionomics shares more than 18% higher to $0.545.

To read the full story, please click here

Pie Funds Management Makes the Deloitte Fast 50 for the Third Year in a Row

Pie Funds is a boutique investment manager with one philosophy: invest wisely, sleep easy. Pie has made the Deloitte Fast 50 once again with impressive revenue growth.

The secret to Founder/CEO Mike Taylor’s success? Check out his 5 tips for successful investing


Pie Funds is a boutique fund manager based in Auckland, New Zealand, managing $250m in assets and specialises in investing in small companies. Their strategy is to focus on the most inefficient part of the equity markets where the potential is greatest for long term returns. Pie Funds has won numerous awards as a business, including fastest growing services company in the Deloitte Fast50, 2014.




SUDA Allowed First USA Patent for SUD-003 and SUD-004

8th October 2015, ASX Announcement

SUDA has been allowed its first patent in the USA for “Oral Spray Formulations and Methods for Administration of Sildenafil” for the treatment of SSRI-induced erectile dysfunction and pulmonary arterial hypertension 

SUDA Ltd (ASX:SUD), a leader in mucosal drug delivery, today announces that the US Patent and Trademark Office has allowed SUDA’s first patent application for its sildenafil based products, SUD-003 and SUD-004, in the USA. The patent application (US 14/363,245) is titled: Oral Spray Formulations and Methods for Administration of Sildenafil. A patent directed to similar subject matter has already been granted in New Zealand and patent applications are pending in other jurisdictions.

The allowed claims of US 14/363,245 cover the administration of sildenafil, being the active pharmaceutical ingredient in SUD-003 and SUD-004, via oral spray formulations at a pH of between 1.5 and 2.4 for the treatment of sexual dysfunction induced by Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants and for the treatment of pulmonary arterial hypertension.

SSRI-induced sexual dysfunction is a common condition, affecting up to 75% of patients taking SSRIs such as Prozac®, Zoloft® and Paxil®.

PAH is a disease that affects the blood pressure between the heart and the lungs. PAH occurs at all ages; however, the incidence of it increases with age. It is is more common among women, non-Hispanic blacks, and among people aged 75 or older, and heart failure is often linked to the disease. The PAH market is forecast to grow at a CAGR of 5% and to reach $3.6 billion in 2015 (source: Global Data Analysis).

The allowance of US 14/363,245 complements SUDA’s intellectual property portfolio directed to the use of oral spray formulations of sildenafil in the treatment of erectile dysfunction. The Company has a second sildenafil patent family, based on PCT/US2011/03942, which contains patents that have been granted in Australian and Singapore with further patent applications that are pending in the USA and other jurisdictions.

Mr Stephen J Carter, SUDA’s CEO and Managing Director, commented: “We are delighted to have been allowed this patent in the USA. It reinforces our proprietary position covering the oral spray delivery of sildenafil for erectile dysfunction and pulmonary arterial hypertension. Pfizer’s sildenafil tablet, Viagra®, achieved sales of US$1.7 billion in 2014 with the majority generated from sales the US market. Having a strong patent position, particularly in the USA, is critical to our partnering strategy with the pharmaceutical industry.”

To read the full announcement, please click on the link below. 

Appointment of Deputy Chairperson at Big Un Limited

8th October 2015, ASX Announcement

Big Un Limited is pleased to announce the appointment of executive director, Sonia Thurston, as Deputy Chairperson of Directors of the Company.

Ms Thurston will act as Chairperson of the Company’s Extraordinary General Meeting to be held on Monday, 12 October 2015, in the absence of Mr Andrew Corner, Chairperson of the Directors. Mr Cornerstone is currently overseas on Company business.

To read the full announcement, please click here

OncoSil strengthens management team

8th October 2015, ASX Announcement

OncoSil Medical Limited (ASX:OSL) (OncoSil Medical, the Company) is pleased to announces details of two new key appointments to its senior management team in preparation for the commercialisation of the Company’s OncoSilTM localised radiation treatment for cancer.

Mr David James appointed Global Head of Manufacturing Operations 

Mr David James has been appointed the Company’s Global Head of Manufacturing Operations on a full-time basis effective from 5 October 2015, after initially working in the role in a part-time consultancy capacity since February.

Mr James is a highly experienced pharmaceutical manufacturing operations executive with more that 20 years’ experience in this field, including six years with leading cancer treatment company Sirtex Medical (ASX:SRX) as Global Operations Manager.

Dr Greg Rogers appointed Manufacturing Engineering Manager 

The Company is also pleased to advise the appointment of Dr Greg Rogers as Manufacturing Engineering Manager, effective from 2 Novemebr 2015.

To read the full announcement please click here